School of Health & Wellbeing

Articles

Ang, D. T.Y. et al. (2024) Coronary microvascular function and atherosclerotic plaque burden in ischaemia and no obstructive coronary arteries: a secondary analysis of the CorMicA trial. Heart, (doi: 10.1136/heartjnl-2024-324677) (PMID:39603791) (Early Online Publication)

Ang, D. T.Y., Carrick, D., Kamdar, A. , Sykes, R. , McGeoch, R. J., Collison, D., McConnachie, A. and Berry, C. (2024) Intracoronary adenosine–derived coronary flow reserve and index of microvascular resistance. Circulation: Cardiovascular Interventions, 17(6), e013667. (doi: 10.1161/circinterventions.123.013667) (PMID:38716671) (PMCID:PMC11177601)

Blair, S. et al. (2024) The Social and Emotional Education and Development intervention to address wellbeing in primary school age children: the SEED cluster RCT. Public Health Research, 12(6), (doi: 10.3310/LYRQ5047) (PMID:38940833)

Bull, C. J. et al. (2024) Impact of weight loss on cancer-related proteins in serum: results from a cluster randomised controlled trial of individuals with type 2 diabetes. EBioMedicine, 100, 104977. (doi: 10.1016/j.ebiom.2024.104977) (PMID:38290287) (PMCID:PMC10844806)

Carberry, J. et al. (2024) Empagliflozin to prevent progressive adverse remodelling after myocardial infarction (EMPRESS-MI): rationale and design. ESC Heart Failure, 11(4), pp. 2001-2012. (doi: 10.1002/ehf2.14830) (PMID:38715187) (PMCID:PMC11287338)

Carberry, J. et al. (2024) Empagliflozin to prevent worsening of left ventricular volumes and systolic function after myocardial infarction (EMPRESS-MI). European Journal of Heart Failure, (doi: 10.1002/ejhf.3560) (Early Online Publication)

Cleland, J. G.F. et al. (2024) Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trial. European Heart Journal, 45(16), pp. 1410-1426. (doi: 10.1093/eurheartj/ehae086) (PMID:38446126) (PMCID:PMC11032711)

Corbin, L. J. et al. (2024) The metabolomic signature of weight loss and remission in the Diabetes Remission Clinical Trial (DiRECT). Diabetologia, 67(1), pp. 74-87. (doi: 10.1007/s00125-023-06019-x) (PMID:37878066) (PMCID:PMC10709482)

Curtain, J. P. et al. (2024) Measuring congestion with a non-invasive monitoring device in heart failure and haemodialysis: CONGEST-HF. European Journal of Heart Failure, 26(6), pp. 1383-1392. (doi: 10.1002/ejhf.3290) (PMID:38741283)

Duncan, S. F. et al. (2024) Radiograph accelerated detection and identification of cancer in the lung (RADICAL): a mixed methods study to assess the clinical effectiveness and acceptability of Qure.ai artificial intelligence software to prioritise chest X-ray (CXR) interpretation. BMJ Open, (doi: 10.1136/bmjopen-2023-081062)

Eldabe, S. et al. (2024) In reply: does a screening trial for spinal cord stimulation in patients with chronic pain of neuropathic origin have clinical utility (TRIAL-STIM)? 36-month results from a randomized controlled trial. Neurosurgery, (doi: 10.1227/neu.0000000000002922) (PMID:38517191) (Early Online Publication)

Ensam, B. et al. (2024) Type 1 Brugada pattern may be provoked by ajmaline in some healthy subjects: results from a clinical trial. Circulation, 149(21), pp. 1693-1695. (doi: 10.1161/circulationaha.123.067223) (PMID:38768273) (PMCID:PMC11115450)

Foley, P.W. et al. (2024) Effect of correcting iron deficiency on the risk of serious infection in heart failure insights from the IRONMAN trial. European Journal of Heart Failure, (doi: 10.1002/ejhf.3504) (PMID:39453738) (Early Online Publication)

Graham, F. J., Guha, K., Cleland, J. G. and Kalra, P. R. (2024) Treating iron deficiency in patients with heart failure: what, why, when, how, where and who. Heart, (doi: 10.1136/heartjnl-2022-322030) (PMID:39160066) (Early Online Publication)

Haag, L. et al. (2024) Baseline characteristics in the Remote Diet Intervention to REduce long-COVID Symptoms Trial (ReDIRECT). NIHR Open Research, 4, 7. (doi: 10.3310/nihropenres.13522.1) (PMID:39145102) (PMCID:PMC11320183)

Hageman, S. H..J. et al. (2024) Prediction of individual lifetime cardiovascular risk and potential treatment benefit: development and recalibration of the LIFE-CVD2 model to four European risk regions. European Journal of Preventive Cardiology, (doi: 10.1093/eurjpc/zwae174) (PMID:38752762) (Early Online Publication)

Highton, P. et al. (2024) Non-pharmacological interventions to improve cardiovascular risk factors in people with diabetic foot disease: a systematic review and meta-analysis. Diabetes Research and Clinical Practice, 209, 111590. (doi: 10.1016/j.diabres.2024.111590) (PMID:38403175)

Johnson, C. F., Ingram, F., Thomson, F., Srireddy, P., Jani, B. D. and Greenlaw, N. (2024) General practice pharmacist-led antipsychotic physical health monitoring: A prospective intervention scoping study. Family Practice, 41(1), pp. 41-49. (doi: 10.1093/fampra/cmad120) (PMID:38180874)

Joy, G. et al. (2024) Electrophysiological characterization of subclinical and overt hypertrophic cardiomyopathy by magnetic resonance imaging-guided electrocardiography. Journal of the American College of Cardiology, 83(11), pp. 1042-1055. (doi: 10.1016/j.jacc.2024.01.006) (PMID:38385929) (PMCID:PMC10945386)

Karmacharya, B. et al. (2024) A service evaluation of weight management for glycaemic control and remission of type 2 diabetes using traditional food in Nepal (Ho-DIRECT NEPAL): a single-arm trial. Lancet Regional Health – Southeast Asia, 29, 100465. (doi: 10.1016/j.lansea.2024.100465)

Kingsmore, D., Edgar, B., Stevenson, K., Greenlaw, N. , Aitken, E., Jackson, A. and Thomson, P. (2024) A practical review of barriers and challenges to a definitive randomised trial of grafts versus fistula. Journal of Vascular Access, (doi: 10.1177/11297298241234610) (PMID:38436199) (Early Online Publication)

Lambourg, E. J. et al. (2024) Stopping versus continuing metformin in patients with advanced CKD: A nationwide Scottish target trial emulation study. American Journal of Kidney Diseases, (doi: 10.1053/j.ajkd.2024.08.012) (PMID:39521399) (In Press)

Lang, J., Wylie, G., Haig, C. , Gillberg, C. and Minnis, H. (2024) Towards system redesign: An exploratory analysis of neurodivergent traits in a childhood population referred for autism assessment. PLoS ONE, 19(1), e0296077. (doi: 10.1371/journal.pone.0296077) (PMID:38198484) (PMCID:PMC10781046)

Lean, M. E.J. et al. (2024) 5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study. Lancet Diabetes and Endocrinology, 12(4), pp. 233-246. (doi: 10.1016/S2213-8587(23)00385-6) (PMID:38423026)

Lee, M. et al. (2024) Administration of ferric derisomaltose for iron deficiency and heart failure during hospital admission or at the clinic – insights from the IRONMAN trial. European Journal of Heart Failure, 26(10), pp. 2293-2295. (doi: 10.1002/ejhf.3394) (PMID:39078467)

Lowrie, R. et al. (2024) Holistic health and social care outreach for people experiencing homelessness with recent non-fatal overdose in Glasgow, Scotland: the Pharmacist and third sector Homeless charity worker Outreach Engagement Non-medical Independent prescriber Rx (PHOENIx) pilot randomised controlled trial. BMJ Public Health, 2(1), e000219. (doi: 10.1136/bmjph-2023-000219)

MacDonald, A. S. et al. (2024) Allopurinol and blood pressure variability following ischemic stroke and transient ischemic attack: a secondary analysis of XILO-FIST. Journal of Human Hypertension, 38, pp. 307-313. (doi: 10.1038/s41371-024-00906-5) (PMID:38438602) (PMCID:PMC11001576)

Mackenzie, I. S. et al. (2024) Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease: the ALL-HEART RCT and economic evaluation. Health Technology Assessment, 28(18), pp. 1-55. (doi: 10.3310/ATTM4092) (PMID:38551218)

MacKenzie, R. M. et al. (2024) Clinical outcomes and adverse events of bariatric surgery in adults with severe obesity in Scotland: the SCOTS observational cohort study. Health Technology Assessment, 28(7), (doi: 10.3310/UNAW6331)

Malamud, M. et al. (2024) Recognition and control of neutrophil extracellular trap formation by MICL. Nature, 633(8029), pp. 442-450. (doi: 10.1038/s41586-024-07820-3) (PMID:39143217)

McCallum, L. et al. (2024) UMOD genotype-dependent effects of Torasemide on ambulatory blood pressure: a multicentre genotype-blinded trial. Hypertension, 81(10), pp. 2049-2059. (doi: 10.1161/HYPERTENSIONAHA.124.23122) (PMID:39077768) (PMCID:PMC11460757)

McConnachie, A. , Mitchell, A., Somerville, L., Williams, N., McGhie, J., McGinn, G. and Lee, J. (2024) Response to Letter to Editor. British Journal of Pain, (doi: 10.1177/20494637241264633) (Early Online Publication)

McGovern, C., McKinley, G., McConnachie, A. , Arkoulis, N., Paton, L., Quasim, T. and Puxty, K. (2024) Long term mortality in burn injury survivors: a matched cohort study. Injury, 55(10), 111793. (doi: 10.1016/j.injury.2024.111793) (PMID:39111270)

Mesquita, L. A. et al. (2024) Does metformin reduce the risk of cancer in obesity and diabetes? A systematic review and meta‐analysis. Diabetes, Obesity and Metabolism, 26(5), pp. 1929-1940. (doi: 10.1111/dom.15509) (PMID:38389430)

Mitchell, A., Somerville, L., Williams, N., McGhie, J., McConnachie, A. , McGinn, G. and Lee, J. (2024) Implanted intrathecal drug delivery systems may be associated with improved survival in patients with cancer. British Journal of Pain, 18(2), pp. 110-119. (doi: 10.1177/20494637231202089) (PMID:38545502)

Morrow, A. et al. (2024) Zibotentan in microvascular angina: a randomized, placebo-controlled, crossover trial. Circulation, (doi: 10.1161/CIRCULATIONAHA.124.069901) (PMID:39217504) (Early Online Publication)

Morrow, A. J. et al. (2024) Socioeconomic deprivation and illness trajectory in the Scottish population after COVID-19 hospitalization. Communications Medicine, 4, 32. (doi: 10.1038/s43856-024-00455-5) (PMID:38418616) (PMCID:PMC10901805)

Osmanska, J. et al. (2024) A novel, small-volume subcutaneous furosemide formulation delivered by an abdominal patch infusor device in patients with heart failure: results of two phase I studies. European Heart Journal: Cardiovascular Pharmacotherapy, 10, pp. 35-44. (doi: 10.1093/ehjcvp/pvad073) (PMID:37804170) (PMCID:PMC10766906)

Petrie, J. R. (2024) Metformin beyond type 2 diabetes: emerging and potential new indications. Diabetes, Obesity and Metabolism, 26(S3), pp. 31-41. (doi: 10.1111/dom.15756) (PMID:38965738)

Ray, R. et al. (2024) The impact of ferric derisomaltose on cardiovascular and non-cardiovascular events in patients with anemia, iron deficiency and heart failure with reduced ejection fraction. Journal of Cardiac Failure, 30(5), pp. 682-690. (doi: 10.1016/j.cardfail.2023.10.006) (PMID:37926238) (PMCID:PMC11096866)

Redgrave, R. E., Singh, E., Tual-Chalot, S., Park, C., Hall, D., Bennaceur, K., Smyth, D. J. , Maizels, R. M. , Spyridopoulos, I. and Arthur, H. M. (2024) Exogenous transforming growth factor-β1 and its helminth-derived mimic attenuate the heart's inflammatory response to ischemic injury and reduce mature scar size. American Journal of Pathology, 194(4), pp. 562-573. (doi: 10.1016/j.ajpath.2023.09.014) (PMID:37832870)

Roger, G. et al. (2024) Chronic coronary syndromes without standard modifiable cardiovascular risk factors and outcomes: the CLARIFY registry. European Heart Journal, 45(27), pp. 2396-2406. (doi: 10.1093/eurheartj/ehae299)

Sabatini, S., Nolan, J. J., O'Donoghue, G., Kennedy, A., Petrie, J. , Walker, M., O'Gorman, D. J. and Gastaldelli, A. (2024) Baseline phenotypes with preserved β-cell function and high insulin concentrations have the best improvements in glucose tolerance after weight loss: results from the prospective DEXLIFE and EGIR-RISC studies. Metabolism, 155, 155910. (doi: 10.1016/j.metabol.2024.155910) (PMID:38599278)

Sidik, N. P. et al. (2024) Invasive endotyping in patients with angina and no obstructive coronary artery disease: a randomized controlled trial. Circulation, 149(1), pp. 7-23. (doi: 10.1161/CIRCULATIONAHA.123.064751) (PMID:37795617)

Sosenko, F. et al. (2024) Cancer diagnosis after emergency presentation: impact of demographics, cancer types, and pandemic. Academia Oncology, 1(2), pp. 1-8. (doi: 10.20935/AcadOnco7422)

Sun, Y., Witham, M. D., Clegg, A., Taylor, R. S. , Dibben, G. , McAllister, D. and Hanlon, P. (2024) A scoping review of the measurement and analysis of frailty in randomised controlled trials. Age and Ageing, 53(11), afae258. (doi: 10.1093/ageing/afae258) (PMID:39572393) (PMCID:PMC11581818)

Suzuki, K. et al. (2024) Genetic drivers of heterogeneity in type 2 diabetes pathophysiology. Nature, 627(8003), pp. 347-357. (doi: 10.1038/s41586-024-07019-6) (PMID:38374256)

Varian, F. et al. (2024) Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14(1), e12337. (doi: 10.1002/pul2.12337) (PMID:38500737) (PMCID:PMC10945040)

Articles

Abdin, A., Komajda, M., Borer, J. S., Ford, I. , Tavazzi, L., Batailler, C., Swedberg, K., Rosano, G. M.C., Mahfoud, F. and Böhm, M. (2023) Efficacy of ivabradine in heart failure patients with a high-risk profile (analysis from the SHIFT trial). ESC Heart Failure, 10(5), pp. 2895-2902. (doi: 10.1002/ehf2.14455) (PMID:37427483) (PMCID:PMC10567656)

Abtan, J. et al. (2023) Association between coffee or tea consumption and cardiovascular outcomes in patients with stable coronary artery disease: Analysis from the CLARIFY registry. Archives of Cardiovascular Diseases, 116(8-9), pp. 382-389. (doi: 10.1016/j.acvd.2023.05.007) (PMID:37524628)

Artico, J. et al. (2023) Myocardial involvement after hospitalization for COVID-19 complicated by troponin elevation: a prospective, multicenter, observational study. Circulation, 147(5), pp. 364-374. (doi: 10.1161/CIRCULATIONAHA.122.060632) (PMID:36705028) (PMCID:PMC9889203)

Azcoaga-Lorenzo, A. et al. (2023) Maternal multimorbidity and preterm birth in Scotland: an observational record-linkage study. BMC Medicine, 21, 352. (doi: 10.1186/s12916-023-03058-4) (PMID:37697325) (PMCID:PMC10496247)

Bhandari, S. et al. (2023) Predictors of quality of life in patients within the first year of commencing haemodialysis based on baseline data from the PIVOTAL trial and associations with the study outcomes. Journal of Nephrology, (doi: 10.1007/s40620-023-01571-6) (PMID:36995528) (PMCID:PMC10061401) (Early Online Publication)

Böhm, M., Abdin, A., Slawik, J., Mahfoud, F., Borer, J., Ford, I. , Swedberg, K., Tavazzi, L., Batailler, C. and Komajda, M. (2023) Time to benefit of heart rate reduction with ivabradine in patients with heart failure and reduced ejection fraction. European Journal of Heart Failure, 25(8), pp. 1429-1435. (doi: 10.1002/ejhf.2870) (PMID:37092340)

Bradley, C. P. et al. (2023) The coronary microvascular angina cardiovascular magnetic resonance imaging trial: rationale and design. American Heart Journal, 265, pp. 213-224. (doi: 10.1016/j.ahj.2023.08.067) (PMID:37657593)

Broadway, K. A. et al. (2023) Loci for insulin processing and secretion provide insight into type 2 diabetes risk. American Journal of Human Genetics, 110(2), pp. 284-299. (doi: 10.1016/j.ajhg.2023.01.002) (PMID:36693378) (PMCID:PMC9943750)

Cassidy, S. et al. (2023) Physical activity, inactivity and sleep during the Diabetes Remission Clinical Trial (DiRECT). Diabetic Medicine, 40(3), e15010. (doi: 10.1111/dme.15010) (PMID:36398460)

Chen, D., Jenkins, A. J., Greenlaw, N. , Dudman, K. , Fernandes, T., Carty, D. M., Hughes, A. D., Januszewski, A. S., Stehouwer, C. D. A. and Petrie, J. R. (2023) Cardiometabolic risk factors, peripheral arterial tonometry and metformin in adults with type 1 diabetes participating in the REducing with MetfOrmin Vascular Adverse Lesions trial. Diabetes and Vascular Disease Research, 20(3), p. 14791641231183634. (doi: 10.1177/14791641231183634) (PMID:37387358) (PMCID:PMC10328035)

Cleland, J. G.F. , Pellicori, P. and Graham, F. J. (2023) Redefining both iron deficiency and anaemia in cardiovascular disease. European Heart Journal, 44(22), pp. 1992-1994. (doi: 10.1093/eurheartj/ehad154) (PMID:36879446)

Cuthbert, J.J., Pellicori, P. , Rigby, A.S., Abel, A.A.I., Kalvickbacka-Bennet, A., Shah, P., Kearsley, J.W., Kazmi, S., Cleland, J.G.F. and Clark, A.L. (2023) Are non-invasive estimations of plasma volume an accurate measure of congestion in patients with chronic heart failure? European Heart Journal: Quality of Care and Clinical Outcomes, 9(3), pp. 281-292. (doi: 10.1093/ehjqcco/qcac035) (PMID:35723241)

Dawson, J. et al. (2023) Xanthine oxidase inhibition and white matter hyperintensity progression following ischaemic stroke and transient ischaemic attack (XILO-FIST): a multicentre, double-blinded, randomised, placebo-controlled trial. EClinicalMedicine, 57, 101863. (doi: 10.1016/j.eclinm.2023.101863) (PMID:36864979) (PMCID:PMC9972492)

Docherty, K. F. et al. (2023) Efficacy of omecamtiv mecarbil in heart failure with reduced ejection fraction according to N‐terminal pro‐B ‐type natriuretic peptide level: insights from the GALACTIC‐HF trial. European Journal of Heart Failure, 25(2), pp. 248-259. (doi: 10.1002/ejhf.2763) (PMID:36597719)

Ferreira, J. P. et al. (2023) Spironolactone effect on cardiac structure and function of patients with heart failure and preserved ejection fraction: a pooled analysis of three randomized trials. European Journal of Heart Failure, 25(1), pp. 108-113. (doi: 10.1002/ejhf.2726) (PMID:36303266)

Ford, I. and Kalra, P. R. (2023) Unanswered questions from the IRONMAN trial - authors' reply. Lancet, 401(10387), pp. 1495-1496. (doi: 10.1016/S0140-6736(23)00448-8) (PMID:37149301)

Gautier, A., Picard, F., Ducrocq, G., Elbez, Y., Fox, K. M., Ferrari, R., Ford, I. , Tardif, J.-C., Tendera, M. and Steg, P. G. (2023) New-onset atrial fibrillation in chronic coronary syndrome: the CLARIFY registry. European Heart Journal, (doi: 10.1093/eurheartj/ehad556) (PMID:37634147) (Early Online Publication)

Goudswaard, L. J. et al. (2023) Using trials of caloric restriction and bariatric surgery to explore the effects of body mass index on the circulating proteome. Scientific Reports, 13, 21077. (doi: 10.1038/s41598-023-47030-x) (PMID:38030643) (PMCID:PMC10686974)

Graham, F., Iaconelli, A., Sonecki, P., Campbell, R. T., Hunter, D., Cleland, J. G.F. and Pellicori, P. (2023) Defining heart failure based on imaging the heart and beyond. Cardiac Failure Review, 9, e11. (doi: 10.15420/cfr.2022.29) (PMID:37427007) (PMCID:PMC10326661)

Graham, F. J., Friday, J. , Pellicori, P. , Greenlaw, N. and Cleland, J. G.F. (2023) Assessment of haemoglobin and serum markers of iron deficiency in people with cardiovascular disease. Heart, 109(17), pp. 1294-1301. (doi: 10.1136/heartjnl-2022-322145) (PMID:37130747)

Graham, F. J., Pellicori, P. , Kalra, P. R., Ford, I. , Bruzzese, D. and Cleland, J. G.F. (2023) Intravenous iron in patients with heart failure and iron deficiency: an updated meta-analysis. European Journal of Heart Failure, 25(4), pp. 528-537. (doi: 10.1002/ejhf.2810) (PMID:36823953)

Graham, F. J., Pellicori, P. , Masini, G., Cuthbert, J. J., Clark, A. L. and Cleland, J. G.F. (2023) Influence of serum transferrin concentration on diagnostic criteria for iron deficiency in chronic heart failure. ESC Heart Failure, 10(5), pp. 2826-2836. (doi: 10.1002/ehf2.14438) (PMID:37400990) (PMCID:PMC10567655)

Haag, L. et al. (2023) The remote diet intervention to reduce Long COVID symptoms trial (ReDIRECT): protocol for a randomised controlled trial to determine the effectiveness and cost-effectiveness of a remotely delivered supported weight management programme for people with Long COVID and excess weight, with personalised improvement goals. NIHR Open Research, 2, 57. (doi: 10.3310/nihropenres.13315.2) (PMID:37881302) (PMCID:PMC10593354)

Hlatky, M. A. et al. (2023) Randomized comparison of chest pain evaluation with FFRCT or standard care: factors determining US costs. Journal of Cardiovascular Computed Tomography, 17(1), pp. 52-59. (doi: 10.1016/j.jcct.2022.09.005) (PMID:36216700)

Iaconelli, A., Pellicori, P. , Caiazzo, E., Rezig, A. O. M. , Bruzzese, D., Maffia, P. and Cleland, J. G. F. (2023) Implanted haemodynamic telemonitoring devices to guide management of heart failure: a review and meta-analysis of randomised trials. Clinical Research in Cardiology, 112(8), pp. 1007-1019. (doi: 10.1007/s00392-022-02104-0) (PMID:36241896) (PMCID:PMC9568893)

Inciardi, R., Pellicori, P. and Chandra, A. (2023) Identification and quantification of congestion in heart failure: a work in progress. European Journal of Heart Failure, 25(1), pp. 61-62. (doi: 10.1002/ejhf.2751) (PMID:36464796)

Jäger, M., Zangger, G., Bricca, A., Dideriksen, M., Smith, S. M., Midtgaard, J., Taylor, R. S. and Skou, S. T. (2023) Mapping interventional components and behaviour change techniques used to promote self-management in people with multimorbidity: a scoping review. Health Psychology Review, (doi: 10.1080/17437199.2023.2182813) (PMID:36811829) (Early Online Publication)

Jamieson, M., Mcclelland, H. , Goudie, N., McFarlane, J., Cullen, B. , Lennon, M., Brewster, S. , Stanley, B. , McConnachie, A. and Evans, J. (2023) AppReminders – a pilot feasibility randomized controlled trial of a memory aid app for people with acquired brain injury. Neuropsychological Rehabilitation, (doi: 10.1080/09602011.2023.2220969) (PMID:37310032) (Early Online Publication)

Jones, R. E. et al. (2023) Assessment of left ventricular tissue mitochondrial bioenergetics in patients with stable coronary artery disease. Nature Cardiovascular Research, 2(8), pp. 733-745. (doi: 10.1038/s44161-023-00312-z)

Keast, T. et al. (2023) Study protocol for IMPRoVE: a multicentre prospective observational cohort study of the incidence, impact and mechanisms of perioperative right ventricular dysfunction in non-cardiac surgery. BMJ Open, 13(9), e074687. (doi: 10.1136/bmjopen-2023-074687) (PMID:37673452) (PMCID:PMC10496661)

Kenny, E., Coyne, R., McEvoy, J. W., McSharry, J., Taylor, R. S. and Byrne, M. (2023) Behaviour change techniques and intervention characteristics in digital cardiac rehabilitation: a systematic review and meta-analysis of randomised controlled trials. Health Psychology Review, (doi: 10.1080/17437199.2023.2185653) (PMID:36892523) (Early Online Publication)

Lee, S. I. et al. (2023) Key outcomes for reporting in studies of pregnant women with multiple long-term conditions: a qualitative study. BMC Pregnancy and Childbirth, 23(1), 551. (doi: 10.1186/s12884-023-05773-5) (PMID:37528358) (PMCID:PMC10391909)

Lee, S. I. et al. (2023) Maternal and child outcomes for pregnant women with pre-existing multiple long-term conditions: protocol for an observational study in the UK. BMJ Open, 13(2), e068718. (doi: 10.1136/bmjopen-2022-068718) (PMID:36828655) (PMCID:PMC9972454)

Li, B., Li, X., Stoet, G. and Lages, M. (2023) Processing speed predicts mean performance in task-switching but not task-switching cost. Psychological Reports, 126(4), pp. 1822-1846. (doi: 10.1177/00332941211072228) (PMID:35084254)

Lo, S. et al. (2023) Participatory development of a 3D telemedicine system during Covid: the future of remote consultations. Journal of Plastic, Reconstructive and Aesthetic Surgery, 87, pp. 479-490. (doi: 10.1016/j.bjps.2022.10.012) (PMID:36890078)

MacBeth, A., Mcskimming, P., Bhattacharya, S., Park, J., Gumley, A. , St Clair, D. and Berry, S. J.E. (2023) General and age-specific fertility rates in non-affective psychosis: population-based analysis of Scottish women. Social Psychiatry and Psychiatric Epidemiology, 58(1), pp. 105-112. (doi: 10.1007/s00127-022-02313-y) (PMID:35648175) (PMCID:PMC9845143)

Mangion, K. et al. (2023) Post-COVID-19 illness and associations with sex and gender. BMC Cardiovascular Disorders, 23, 389. (doi: 10.1186/s12872-023-03412-7) (PMID:37553628) (PMCID:PMC10408208)

McConnachie, A. , Ellis, D. E., Wilson, P., McQueenie, R. and Williamson, A. E. (2023) Quantifying unmet need in General Practice: a retrospective cohort study of administrative data. BMJ Open, 13(9), e068720. (doi: 10.1136/bmjopen-2022-068720) (PMID:37714681)

Melville, C.A. et al. (2023) Predictors and moderators of the response of adults with intellectual disabilities and depression to behavioural activation and guided self-help therapies. Journal of Intellectual Disability Research, 67(10), pp. 986-1002. (doi: 10.1111/jir.13063) (PMID:37344986)

Mitchell, A., Somerville, L., Williams, N., McGhie, J., McConnachie, A. , McGinn, G. and Lee, J. (2023) More time in a community setting: A service evaluation of the impact of intrathecal drug delivery systems on place of care of patients with cancer pain. Palliative Medicine, (doi: 10.1177/02692163231191548) (PMID:37632373) (Early Online Publication)

Mooney, L., Jackson, C. E., Adamson, C., McConnachie, A. , Welsh, P. , Myles, R. C. , McMurray, J. J.V. , Jhund, P. S. , Petrie, M. C. and Lang, N. N. (2023) Adverse outcomes associated with interleukin-6 in patients recently hospitalized for heart failure with preserved ejection fraction. Circulation: Heart Failure, 16(4), e010051. (doi: 10.1161/CIRCHEARTFAILURE.122.010051) (PMID:36896709) (PMCID:PMC10101136)

Nuzzi, V. et al. (2023) Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications. Clinical Research in Cardiology, 112(3), pp. 419-430. (doi: 10.1007/s00392-022-02126-8) (PMID:36385396) (PMCID:PMC9998319)

Ouwerkerk, W. et al. (2023) Association of time‐to‐IV ‐furosemide with mortality in acute heart failure: data from REPORT‐HF. European Journal of Heart Failure, 25(1), pp. 43-51. (doi: 10.1002/ejhf.2708) (PMID:36196060)

Pauls, M. M.H. et al. (2023) Testing the cognitive effects of tadalafil. Neuropsychological secondary outcomes from the PASTIS trial. Cerebral Circulation - Cognition and Behavior, 5, 100187. (doi: 10.1016/j.cccb.2023.100187) (PMID:37811523) (PMCID:PMC10550803)

Petrie, M. C. et al. (2023) High-dose intravenous iron reduces myocardial infarction in patients on haemodialysis. Cardiovascular Research, 119(1), pp. 213-220. (doi: 10.1093/cvr/cvab317) (PMID:34875022) (PMCID:PMC10022850)

Purcell, C. , Purvis, A., Cleland, J. G.F. , Cowie, A., Dalal, H. M., Ibbotson, T. , Murphy, C. and Taylor, R. S. (2023) Home-based cardiac rehabilitation for people with heart failure and their caregivers: a mixed-methods analysis of the roll out an evidence-based programme in Scotland (SCOT:REACH-HF study). European Journal of Cardiovascular Nursing, 22(8), pp. 804-813. (doi: 10.1093/eurjcn/zvad004) (PMID:36617216)

Robb, K. A. et al. (2023) Increasing uptake of FIT colorectal screening: protocol for the TEMPO randomised controlled trial testing a suggested deadline and a planning tool. BMJ Open, 13(5), e066136. (doi: 10.1136/bmjopen-2022-066136) (PMID:37202130) (PMCID:PMC10201271)

Rotbain Curovic, V. et al. (2023) Presence of retinopathy and incident kidney and cardiovascular events in type 2 diabetes with normoalbuminuria – a post-hoc analysis of the PRIORITY randomized clinical trial. Journal of Diabetes and its Complications, 37(4), 108433. (doi: 10.1016/j.jdiacomp.2023.108433) (PMID:36841085)

Savarese, G., von Haehling, S., Butler, J., Cleland, J. G.F. , Ponikowski, P. and Anker, S. D. (2023) Iron deficiency and cardiovascular disease. European Heart Journal, 44(1), pp. 14-27. (doi: 10.1093/eurheartj/ehac569) (PMID:36282723) (PMCID:PMC9805408)

Stähli, B. E. et al. (2023) Timing of complete revascularization with multivessel PCI for myocardial infarction. New England Journal of Medicine, 389(15), pp. 1368-1379. (doi: 10.1056/NEJMoa2307823) (PMID:37634190)

Subramanian, A. et al. (2023) Polypharmacy during pregnancy and associated risk factors: a retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000-2019. BMC Medicine, 21, 21. (doi: 10.1186/s12916-022-02722-5) (PMID:36647047) (PMCID:PMC9843951)

Sullivan, M. K. et al. (2023) Potential impact of NICE guidelines on referrals from primary care to nephrology: a primary care database and prospective research study. British Journal of General Practice, 73(727), e141-e147. (doi: 10.3399/BJGP.2022.0145) (PMID:36376072) (PMCID:PMC9678375)

Sykes, R. et al. (2023) Adjudicated myocarditis and multisystem illness trajectory in healthcare workers post-COVID-19. Open Heart, 10(1), e002192. (doi: 10.1136/openhrt-2022-002192) (PMID:36822817) (PMCID:PMC9950584)

Sykes, R. A. et al. (2023) Vascular mechanisms of post-COVID-19 conditions: rho-kinase is a novel target for therapy. European Heart Journal: Cardiovascular Pharmacotherapy, 9(4), pp. 371-386. (doi: 10.1093/ehjcvp/pvad025) (PMID:37019821) (PMCID:PMC10236521)

Tun, H. N., Khan, H., Chernikova, D., Mareev, Y., Chakrabarti, S., Thant, M. and Cannata, A. (2023) Conduction system pacing: promoting the physiology to prevent heart failure. Heart Failure Reviews, 28(2), pp. 379-386. (doi: 10.1007/s10741-023-10296-4) (PMID:36781809)

van der Klaauw, A. A. et al. (2023) Accelerated waning of the humoral response to COVID-19 vaccines in obesity. Nature Medicine, 29(5), pp. 1146-1154. (doi: 10.1038/s41591-023-02343-2) (PMID:37169862) (PMCID:PMC10202802)

Vidal-Petiot, E., Elbez, Y., Mesnier, J., Ducrocq, G., Ford, I. , Tendera, M., Ferrari, R., Tardif, J.-C., Fox, K. M. and Steg, P. G. (2023) Optimal or standard control of systolic and diastolic blood pressure across risk factor categories in patients with chronic coronary syndromes. European Journal of Preventive Cardiology, 30(10), pp. 935-947. (doi: 10.1093/eurjpc/zwad004) (PMID:36617264)

Walker-Bone, K., Macfarlane, G. J., Burton, K., McConnachie, A. M. , Zhang, R. and Jones, G. T. (2023) Advice to remain active with arm pain reduces disability. Occupational Medicine, 73(5), pp. 268-274. (doi: 10.1093/occmed/kqad065) (PMID:37261458)

Wang, H. et al. (2023) Cardiovascular safety in type 2 diabetes with sulfonylureas as second-line drugs: a nation-wide population-based comparative safety study. Diabetes Care, 46(5), pp. 967-977. (doi: 10.2337/dc22-1238) (PMID:36944118) (PMCID:PMC10154665)

Whinnett, Z. I. et al. (2023) Effects of haemodynamically atrio‐ventricular optimized His‐pacing on heart failure symptoms and exercise capacity: the His Optimized Pacing Evaluated for Heart Failure (HOPE‐HF) randomised, double‐blind, cross‐over trial. European Journal of Heart Failure, 25(2), pp. 274-283. (doi: 10.1002/ejhf.2736) (PMID:36404397)

Wu, X. et al. (2023) [11C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trial. Nature Medicine, 29(1), pp. 190-202. (doi: 10.1038/s41591-022-02114-5) (PMID:36646800)

Yeoh, S. E. et al. (2023) Dapagliflozin versus metolazone in heart failure resistant to loop diuretics. European Heart Journal, 44(31), pp. 2966-2977. (doi: 10.1093/eurheartj/ehad341) (PMID:37210742)

Young, W. J. et al. (2023) Genetic architecture of spatial electrical biomarkers for cardiac arrhythmia and relationship with cardiovascular disease. Nature Communications, 14, 1411. (doi: 10.1038/s41467-023-36997-w) (PMID:36918541) (PMCID:PMC10015012)

Zanetti, D. et al. (2023) Plasma proteomic signatures of a direct measure of insulin sensitivity in two population cohorts. Diabetologia, 66(9), pp. 1643-1654. (doi: 10.1007/s00125-023-05946-z) (PMID:37329449)

Conference or Workshop Item

Lowrie, R. et al. (2023) Home Intervention for Patients with Moderate-severe COPD and Co-morbidities by Pharmacists and Physicians: Methods and Baseline Characteristics from a Pilot RCT. ERS International Congress 2023, Milan, Italy, 9-13 Sept 2023. (doi: 10.1183/13993003.congress-2023.pa546)

Articles

Aktaa, S. et al. (2022) Data standards for heart failure: the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart). European Heart Journal, 43(23), pp. 2185-2195. (doi: 10.1093/eurheartj/ehac151) (PMID:35443059)

Al-Zaiti, S. S., Alghwiri, A. A., Hu, X., Clermont, G., Peace, A., Macfarlane, P. and Bond, R. (2022) A clinician’s guide to understanding and critically appraising machine learning studies: a checklist for Ruling Out Bias Using Standard Tools in Machine Learning (ROBUST-ML). European Heart Journal: Digital Health, 3(2), pp. 125-140. (doi: 10.1093/ehjdh/ztac016) (PMID:36713011) (PMCID:PMC9708024)

Alnuwaysir, R. I.S. et al. (2022) Additional burden of iron deficiency in heart failure patients beyond the cardio‐renal anaemia syndrome: findings from the BIOSTAT‐CHF study. European Journal of Heart Failure, 24(1), pp. 192-204. (doi: 10.1002/ejhf.2393) (PMID:34816550)

Austin, R. C., Schoonhoven, L., Koutra, V., Richardson, A., Kalra, P. R. and May, C. R. (2022) SYMptoms in chronic heart failure imPACT on burden of treatment (SYMPACT): a cross‐sectional survey. ESC Heart Failure, 9(4), pp. 2279-2290. (doi: 10.1002/ehf2.13904) (PMID:35451208) (PMCID:PMC9288776)

Bauer, B. S., Azcoaga-Lorenzo, A., Agrawal, U., Fagbamigbe, A. F. and McCowan, C. (2022) The impact of the management strategies for patients with subclinical hypothyroidism on long-term clinical outcomes: an umbrella review. PLoS ONE, 17(5), e0268070. (doi: 10.1371/journal.pone.0268070) (PMID:35587500) (PMCID:PMC9119548)

Baumhove, L. et al. (2022) Heart failure with normal LVEF in BIOSTAT-CHF. International Journal of Cardiology, 364, pp. 85-90. (doi: 10.1016/j.ijcard.2022.05.054) (PMID:35649488)

Bomer, N., Pavez-Giani, M. G., Grote Beverborg, N., Cleland, J. G.F. , van Veldhuisen, D. J. and van der Meer, P. (2022) Micronutrient deficiencies in heart failure: mitochondrial dysfunction as a common pathophysiological mechanism? Journal of Internal Medicine, 291(6), pp. 713-731. (doi: 10.1111/joim.13456) (PMID:35137472) (PMCID:PMC9303299)

Borlaug, B. A. et al. (2022) Latent pulmonary vascular disease may alter the response to therapeutic atrial shunt device in heart failure. Circulation, 145(21), pp. 1592-1604. (doi: 10.1161/CIRCULATIONAHA.122.059486) (PMID:35354306) (PMCID:PMC9133195)

Boyalla, V. et al. (2022) Biomarkers as predictors of recurrence of atrial fibrillation post ablation: an updated and expanded systematic review and meta-analysis. Clinical Research in Cardiology, 111(6), pp. 680-691. (doi: 10.1007/s00392-021-01978-w) (PMID:34999932) (PMCID:PMC9151522)

Bracun, V. et al. (2022) Insulin‐like growth factor binding protein 7 (IGFBP7), a link between heart failure and senescence. ESC Heart Failure, 9(6), pp. 4167-4176. (doi: 10.1002/ehf2.14120) (PMID:36088651) (PMCID:PMC9773704)

Brandes, A. et al. (2022) Consumer-led screening for atrial fibrillation: Frontier review of the AF-SCREEN International Collaboration. Circulation, 146(19), pp. 1461-1474. (doi: 10.1161/circulationaha.121.058911) (PMID:36343103)

Bularga, A. et al. (2022) Assessment of oxygen supply-demand imbalance and outcomes among patients with type 2 myocardial infarction: a secondary analysis of the High-STEACS cluster randomized clinical trial. JAMA Network Open, 5(7), e2220162. (doi: 10.1001/jamanetworkopen.2022.20162) (PMID:35816305) (PMCID:PMC9274319)

Butler, J. et al. (2022) Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial. European Heart Journal, 43(41), pp. 4362-4373. (doi: 10.1093/eurheartj/ehac401) (PMID:35900838) (PMCID:PMC9622299)

Butterly, E. et al. (2022) Calibrating a network meta-analysis of diabetes trials of sodium glucose cotransporter 2 inhibitors, glucagon-like peptide-1 receptor analogues and dipeptidyl peptidase-4 inhibitors to a representative routine population: a systematic review protocol. BMJ Open, 12(10), e066491. (doi: 10.1136/bmjopen-2022-066491) (PMID:36302574) (PMCID:PMC9621152)

Caiazzo, E., Rezig, A. O.M. , Bruzzese, D., Ialenti, A., Cicala, C., Cleland, J. G.F. , Guzik, T. J., Maffia, P. and Pellicori, P. (2022) Systemic administration of glucocorticoids, cardiovascular complications and mortality in patients hospitalised with COVID-19, SARS, MERS or influenza: a systematic review and meta-analysis of randomised trials. Pharmacological Research, 176, 106053. (doi: 10.1016/j.phrs.2021.106053) (PMID:34979235) (PMCID:PMC8719379)

Cester, L., Starshynov, I. , Jones, Y., Pellicori, P. , Cleland, J. G.F. and Faccio, D. (2022) Remote laser-speckle sensing of heart sounds for health assessment and biometric identification. Biomedical Optics Express, 13(7), pp. 3743-3750. (doi: 10.1364/BOE.451416) (PMID:35991923) (PMCID:PMC9352283)

Chugunov, I. A., Mareev, Y.V., Fudim, M., Mironova, N. A., Mareev, V. Y. and Davtyan, R. V. (2022) Cardiac contractility modulation in heart failure with reduced ejection fraction treatment. Kardiologiia, 62(11), pp. 71-78. (doi: 10.18087/cardio.2022.11.n2014) (PMID:36521047)

Cleland, J. G.F. (2022) Aspirin for primary and secondary prevention of cardiovascular disease: time to stop? Thrombosis and Haemostasis, 122(3), pp. 311-314. (doi: 10.1055/s-0041-1740639) (PMID:35052007)

Cleland, J. G.F. (2022) Maintaining public trust in medical advice—could less be more? JAMA Network Open, 5(5), e2211113. (doi: 10.1001/jamanetworkopen.2022.11113) (PMID:35536584)

Cleland, J. G.F. et al. (2022) The effect of cardiac resynchronization without a defibrillator on morbidity and mortality: an individual-patient-data meta-analysis of COMPANION and CARE-HF. European Journal of Heart Failure, 24(6), pp. 1080-1090. (doi: 10.1002/ejhf.2524) (PMID:35490339) (PMCID:PMC9543287)

Cleland, J. G.F. , Butler, J., Januzzi, J. L., Pellicori, P. and McDonagh, T. (2022) Only people with increased plasma concentrations of natriuretic peptides should be included in outcome trials of diabetes, cardiovascular and kidney disease: implications for clinical practice. European Journal of Heart Failure, 24(4), pp. 678-680. (doi: 10.1002/ejhf.2488) (PMID:35297132)

Coats, A. J. S. et al. (2022) Atrial disease and heart failure: the common soil hypothesis proposed by the Heart Failure Association of the European Society of Cardiology. European Heart Journal, 43(9), pp. 863-867. (doi: 10.1093/eurheartj/ehab834) (PMID:34875053)

Cohen, D. J., Magnuson, E., Stone, G. W. and Cleland, J. G.F. (2022) Response to: correspondence on 'Cost-effectiveness of transcatheter edge-to-edge repair in secondary mitral regurgitation does need confirmation' by Armoiry and Connock. Heart, 108(13), 1072. (doi: 10.1136/heartjnl-2022-321180) (PMID:35534052)

Cohen, D. J. et al. (2022) Cost-effectiveness of transcatheter edge-to-edge repair in secondary mitral regurgitation. Heart, 108(9), pp. 717-724. (doi: 10.1136/heartjnl-2021-320005) (PMID:35078867) (PMCID:PMC8995818)

Cooper, T. J. et al. (2022) Effects of sildenafil on symptoms and exercise capacity for heart failure with reduced ejection fraction and pulmonary hypertension (the SilHF study): a randomised placebo‐controlled multicentre trial. European Journal of Heart Failure, 24(7), pp. 1239-1248. (doi: 10.1002/ejhf.2527) (PMID:35596935)

Cotton, S. et al. (2022) Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS). Trials, 23, 307. (doi: 10.1186/s13063-022-06226-8) (PMID:35422024) (PMCID:PMC9009490)

Cowie, M. and Cleland, J. G.F. (2022) The COVID-19 pandemic and heart failure: lessons from GUIDE-HF. European Heart Journal, 43(27), pp. 2619-2621. (doi: 10.1093/eurheartj/ehac226) (PMID:35511076) (PMCID:PMC9279113)

Crawford, K. et al. (2022) The Best Services Trial (BeST?): a cluster randomised controlled trial comparing the clinical and cost-effectiveness of New Orleans Intervention Model with Services as Usual (SAU) for infants and young children entering care. Trials, 23, 122. (doi: 10.1186/s13063-022-06007-3) (PMID:35130937) (PMCID:PMC8819875)

Cuthbert, J.J. et al. (2022) Hypochloraemia following admission to hospital with heart failure is common and associated with an increased risk of readmission or death: a report from OPERA-HF. European Heart Journal: Acute Cardiovascular Care, 11(1), pp. 43-52. (doi: 10.1093/ehjacc/zuab097) (PMID:34897402)

de Groot, N. M.S. et al. (2022) Critical appraisal of technologies to assess electrical activity during atrial fibrillation: a position paper from the European Heart Rhythm Association and European Society of Cardiology Working Group on eCardiology in collaboration with the Heart Rhythm Society, Asia Pacific Heart Rhythm Society, Latin American Heart Rhythm Society and Computing in Cardiology. Europace, 24(2), pp. 313-330. (doi: 10.1093/europace/euab254) (PMID:34878119)

Deo, S. V. et al. (2022) Revascularization in ischemic heart failure with preserved ejection fraction: a nationwide cohort study. European Journal of Heart Failure, 24(8), pp. 1427-1438. (doi: 10.1002/ejhf.2446) (PMID:35119162)

Emmens, J. E. et al. (2022) Worsening renal function in acute heart failure in the context of diuretic response. European Journal of Heart Failure, 24(2), pp. 365-374. (doi: 10.1002/ejhf.2384) (PMID:34786794)

Fairbairn, T. et al. (2022) Effect of transcatheter aortic valve implantation vs surgical aortic valve replacement on all-cause mortality in patients with aortic stenosis. JAMA: Journal of the American Medical Association, 327(19), pp. 1875-1887. (doi: 10.1001/jama.2022.5776) (PMID:35579641)

Ferreira, J. P., Cleland, J. G. , Lam, C. S.P., Anker, S. D., Mehra, M. R., van Veldhuisen, D. J., Byra, W. M., LaPolice, D. A., Greenberg, B. and Zannad, F. (2022) New-onset atrial fibrillation in patients with worsening heart failure and coronary artery disease: an analysis from the COMMANDER-HF trial. Clinical Research in Cardiology, 111(1), pp. 50-59. (doi: 10.1007/s00392-021-01891-2) (PMID:34128083)

Ferreira, J. P. et al. (2022) Spironolactone effect on the blood pressure of patients at risk of developing heart failure: an analysis from the HOMAGE trial. European Heart Journal: Cardiovascular Pharmacotherapy, 8(2), pp. 149-156. (doi: 10.1093/ehjcvp/pvab031) (PMID:33822033)

Ferreira, J. P. et al. (2022) Influence of ejection fraction on biomarker expression and response to spironolactone in people at risk of heart failure: findings from the HOMAGE trial. European Journal of Heart Failure, 24(5), pp. 771-778. (doi: 10.1002/ejhf.2455) (PMID:35199421)

Gautier, A., Ducrocq, G., Elbez, Y., Fox, K. M., Ferrari, R., Ford, I. , Tardif, J.-C., Tendera, M., Feldman, L. J. and Steg, P. G. (2022) Cardiovascular risk of chronic coronary syndrome patients according to vascular phenotype, diabetes, and smoking. European Journal of Preventive Cardiology, 29(1), e35-e37. (doi: 10.1093/eurjpc/zwaa137) (PMID:33624093)

Girerd, N. et al. (2022) Inflammation and remodeling pathways and risk of cardiovascular events in patients with ischemic heart failure and reduced ejection fraction. Scientific Reports, 12, 8574. (doi: 10.1038/s41598-022-12385-0) (PMID:35595781) (PMCID:PMC9123183)

Girerd, N. et al. (2022) Practical outpatient management of worsening chronic heart failure. European Journal of Heart Failure, 24(5), pp. 750-761. (doi: 10.1002/ejhf.2503) (PMID:35417093)

Girerd, N. et al. (2022) Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction. ESC Heart Failure, 9(4), pp. 2063-2069. (doi: 10.1002/ehf2.13929) (PMID:35429120) (PMCID:PMC9288781)

Goldberg, L. R., Jorbenadze, A., Shaburishvilli, T., Mirro, M. J., Fudim, M., Zuber, M., Stämpfli, S. F., Tanner, F. C., Erne, P. and Cleland, J. G. (2022) Synchronized diaphragmatic stimulation: a case report of a novel extra-cardiac intervention for chronic heart failure. ESC Heart Failure, 9(3), pp. 1677-1681. (doi: 10.1002/ehf2.13882) (PMID:35297198) (PMCID:PMC9065831)

Graham, F. J., Masini, G., Pellicori, P. , Cleland, J. G.F. , Greenlaw, N. , Friday, J. , Kazmi, S. and Clark, A. L. (2022) Natural history and prognostic significance of iron deficiency and anaemia in ambulatory patients with chronic heart failure. European Journal of Heart Failure, 24(5), pp. 807-817. (doi: 10.1002/ejhf.2251) (PMID:34050582)

Halliday, B. P. and Cleland, J. G. F. (2022) Maintaining success for patients with dilated cardiomyopathy and remission of heart failure. JACC: Basic to Translational Science, 7(5), pp. 500-503. (doi: 10.1016/j.jacbts.2022.03.008) (PMID:35663636) (PMCID:PMC9156436)

Halliday, B. P. et al. (2022) Changes in clinical and imaging variables during withdrawal of heart failure therapy in recovered dilated cardiomyopathy. ESC Heart Failure, 9(3), pp. 1616-1624. (doi: 10.1002/ehf2.13872) (PMID:35257498) (PMCID:PMC9065828)

Hendry, G. J. et al. (2022) Gait rehabilitation for foot and ankle impairments in early rheumatoid arthritis: a feasibility study of a new gait rehabilitation programme (GREAT Strides). Pilot and Feasibility Studies, 8, 115. (doi: 10.1186/s40814-022-01061-9) (PMID:35637495) (PMCID:PMC9150324)

Ho, F. K. et al. (2022) Association of gamma-glutamyltransferase levels with total mortality, liver-related, and cardiovascular outcomes: a prospective cohort study in the UK Biobank. EClinicalMedicine, 48, 101435. (doi: 10.1016/j.eclinm.2022.101435) (PMID:35706481) (PMCID:PMC9112033)

Ho, I. S.-S. et al. (2022) Variation in the estimated prevalence of multimorbidity: systematic review and meta-analysis of 193 international studies. BMJ Open, 12(4), e057017. (doi: 10.1136/bmjopen-2021-057017) (PMID:35487738) (PMCID:PMC9058768)

Idris, I., Zhang, R. , Mamza, J. B., Ford, M., Morris, T., Banerjee, A. and Khunti, K. (2022) Significant reduction in chronic kidney disease progression with sodium glucose co‐transporter‐2 inhibitors compared to dipeptidyl peptidase‐4 inhibitors in adults with type 2 diabetes in UK clinical setting: an observational outcomes study based on international guidelines for kidney disease. Diabetes, Obesity and Metabolism, 24(11), pp. 2138-2147. (doi: 10.1111/dom.14799) (PMID:35676798)

Inciardi, R. M. et al. (2022) Clinical implications of left atrial changes after optimization of medical therapy in patients with heart failure. European Journal of Heart Failure, 24(11), pp. 2131-2139. (doi: 10.1002/ejhf.2593) (PMID:35748048)

Israr, M. Z. et al. (2022) Surrogate markers of gut dysfunction are related to heart failure severity and outcome - from the BIOSTAT-CHF consortium. American Heart Journal, 248, pp. 108-119. (doi: 10.1016/j.ahj.2022.03.002) (PMID:35278373)

Jackson, A. M. et al. (2022) Diabetes and pre‐diabetes in patients with heart failure and preserved ejection fraction. European Journal of Heart Failure, 24(3), pp. 497-509. (doi: 10.1002/ejhf.2403) (PMID:34918855) (PMCID:PMC9542636)

Jorbendaze, A. et al. (2022) Synchronized diaphragmatic stimulation for heart failure using the VisONE system: a first‐in‐patient study. ESC Heart Failure, 9(4), pp. 2207-2214. (doi: 10.1002/ehf2.13984) (PMID:35619238) (PMCID:PMC9288796)

Kalra, P. R. et al. (2022) Rationale and design of a randomised trial of intravenous iron in patients with heart failure. Heart, 108(24), pp. 1979-1985. (doi: 10.1136/heartjnl-2022-321304) (PMID:35948408) (PMCID:PMC9726969)

Kalra, P. R. et al. (2022) Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial. Lancet, 400(10369), pp. 2199-2209. (doi: 10.1016/S0140-6736(22)02083-9) (PMID:36347265)

Kobayashi, M. et al. (2022) The association between markers of type I collagen synthesis and echocardiographic response to spironolactone in patients at risk of heart failure: findings from the HOMAGE trial. European Journal of Heart Failure, 24(9), pp. 1559-1568. (doi: 10.1002/ejhf.2579) (PMID:35703355)

Lahti, J. et al. (2022) Genome-wide meta-analyses reveal novel loci for verbal short-term memory and learning. Molecular Psychiatry, 27(11), pp. 4419-4431. (doi: 10.1038/s41380-022-01710-8) (PMID:35974141) (PMCID:PMC9734053)

Lam, P. H. et al. (2022) Right ventricular ejection fraction and beta-blocker effect in heart failure with reduced ejection fraction: Beta-blocker and outcomes in HFrEF by RVEF. Journal of Cardiac Failure, 28(1), pp. 65-70. (doi: 10.1016/j.cardfail.2021.07.026) (PMID:34419597)

Lee, M. M.Y. et al. (2022) Effect of empagliflozin on kidney biochemical and imaging outcomes in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF). Circulation, 146(4), pp. 364-367. (doi: 10.1161/CIRCULATIONAHA.122.059851) (PMID:35877829)

Lee, S. I. et al. (2022) Epidemiology of pre-existing multimorbidity in pregnant women in the UK in 2018: a population-based cross-sectional study. BMC Pregnancy and Childbirth, 22, 120. (doi: 10.1186/s12884-022-04442-3) (PMID:35148719) (PMCID:PMC8840793)

Lewinter, C., Nielsen, T. H., Edfors, L. R., Linde, C., Bland, J. M., LeWinter, M., Cleland, J. G.F. , Køber, L., Braunschweig, F. and Mansson-Broberg, A. (2022) A systematic review and meta-analysis of beta-blockers and inhibitors of the renin-angiotensin system for preventing left ventricular dysfunction due to anthracyclines or trastuzumab in patients with breast cancer. European Heart Journal, 43(27), pp. 2562-2569. (doi: 10.1093/eurheartj/ehab843) (PMID:34951629)

Livingstone, R. , Bryant, N. J., Boyle, J. G., Petrie, J. R. and Gould, G. W. (2022) Diabetes is accompanied by changes in the levels of proteins involved in endosomal GLUT4 trafficking in obese human skeletal muscle. Endocrinology, Diabetes and Metabolism, 5(5), e361. (doi: 10.1002/edm2.361) (PMID:35964329) (PMCID:PMC9471587)

Lota, A. S. et al. (2022) Genetic architecture of acute myocarditis and the overlap with inherited cardiomyopathy. Circulation, 146(15), pp. 1123-1134. (doi: 10.1161/CIRCULATIONAHA.121.058457) (PMID:36154167) (PMCID:PMC9555763)

Macfarlane, P. W. (2022) The application of computer techniques to ECG interpretation. Hearts, 3(1), pp. 1-5. (doi: 10.3390/hearts3010001)

Mackenzie, I. S. et al. (2022) Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial. Lancet, 400(10361), pp. 1417-1425. (doi: 10.1016/S0140-6736(22)01786-X) (PMID:36240838) (PMCID:PMC9631239)

Mackenzie, I. S. et al. (2022) Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial. Lancet, 400(10359), pp. 1195-1205. (doi: 10.1016/S0140-6736(22)01657-9) (PMID:36216006)

Mahajan, A. et al. (2022) Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation. Nature Genetics, 54(5), pp. 560-572. (doi: 10.1038/s41588-022-01058-3) (PMID:35551307)

Markousis-Mavrogenis, G. et al. (2022) Multimarker profiling identifies protective and harmful immune processes in heart failure: findings from BIOSTAT-CHF. Cardiovascular Research, 118(8), pp. 1964-1977. (doi: 10.1093/cvr/cvab235) (PMID:34264317)

Masini, G., Graham, F. J., Pellicori, P. , Cleland, J. G.F. , Cuthbert, J. J., Kazmi, S., Inciardi, R. M. and Clark, A. L. (2022) Criteria for iron deficiency in patients with heart failure. Journal of the American College of Cardiology, 79(4), pp. 341-351. (doi: 10.1016/j.jacc.2021.11.039) (PMID:35086656)

McCall, P.J. , Willder, J.M., Stanley, B.L. , Messow, C.-M. , Allan, J., Gemmell, L., Puxty, A., Strachan, D., Berry, C. and Shelley, B.G. (2022) Right ventricular dysfunction in patients with COVID-19 pneumonitis whose lungs are mechanically ventilated: a multicentre prospective cohort study. Anaesthesia, 77(7), pp. 772-784. (doi: 10.1111/anae.15745) (PMID:35607911) (PMCID:PMC9322018)

Mccowan, C., Bakhshi, A., McConnachie, A. , Malcolm, W., Barry, S.J.E., Hernandez Santiago, V. H. and Leanord, A. (2022) E. coli bacteraemia and antimicrobial resistance following antimicrobial prescribing for urinary tract infection in the community. BMC Infectious Diseases, 22(1), 805. (doi: 10.1186/s12879-022-07768-7) (PMID:36307776) (PMCID:PMC9621144)

McNaughton, C. D. et al. (2022) Quality of life assessed six months after hospitalisation for acute heart failure: an analysis from REPORT‐HF (International Registry to assess mEdical Practice with lOngitudinal obseRvation for Treatment of Heart Failure). European Journal of Heart Failure, 24(6), pp. 1020-1029. (doi: 10.1002/ejhf.2508) (PMID:35429091)

McParland, C., Cooper, M. A., Lowe, D. J. , Stanley, B. and Johnston, B. (2022) Multimorbidity, disease count, mortality and emergency care use in persons attending the emergency department: a cross-sectional data-linkage study. Journal of Multimorbidity and Comorbidity, 12, p. 26335565221147417. (doi: 10.1177/26335565221147417) (PMID:36545236) (PMCID:PMC9761223)

McPherson, K. E., Wiseman, K., Jasilek, A., McAloney-Kocaman, K., Morawska, A. and Haig, C. (2022) Baby triple P: a randomized controlled trial testing the efficacy in first-time parent couples. Journal of Child and Family Studies, 31(8), pp. 2156-2174. (doi: 10.1007/s10826-022-02345-7)

Mesin, L. et al. (2022) Assessment of phasic changes of vascular size by automated edge tracking-state of the art and clinical perspectives. Frontiers in Cardiovascular Medicine, 8, 775635. (doi: 10.3389/fcvm.2021.775635) (PMID:35127855) (PMCID:PMC8814097)

Monzo, L. et al. (2022) Dyskalemia in people at increased risk for heart failure: findings from the heart ‘OMics’ in AGEing (HOMAGE) trial. ESC Heart Failure, 9(6), pp. 4352-4357. (doi: 10.1002/ehf2.14086) (PMID:36065795) (PMCID:PMC9773649)

Morrow, A. et al. (2022) Prevention and early treatment of the long-term physical effects of COVID-19 in adults: design of a randomised controlled trial of resistance exercise—CISCO-21. Trials, 23, 660. (doi: 10.1186/s13063-022-06632-y) (PMID:35971155) (PMCID:PMC9376905)

Morrow, A. J. et al. (2022) A multisystem, cardio-renal investigation of post-COVID-19 illness. Nature Medicine, 28(6), pp. 1303-1313. (doi: 10.1038/s41591-022-01837-9) (PMID:35606551) (PMCID:PMC9205780)

Mujaj, B. et al. (2022) Aspirin use is associated with increased risk for incident heart failure: a patient-level pooled analysis. ESC Heart Failure, 9(1), pp. 685-694. (doi: 10.1002/ehf2.13688) (PMID:34808706) (PMCID:PMC8787993)

Nath, M. et al. (2022) Whole blood transcriptomic profiling identifies molecular pathways related to cardiovascular mortality in heart failure. European Journal of Heart Failure, 24(6), pp. 1009-1019. (doi: 10.1002/ejhf.2540) (PMID:35570197)

O'Connor, R. C. et al. (2022) SAFETEL: A pilot randomised controlled trial to assess the feasibility and acceptability of a safety planning and telephone follow-up intervention to reduce suicidal behaviour. Pilot and Feasibility Studies, 8, 156. (doi: 10.1186/s40814-022-01081-5) (PMID:35897119) (PMCID:PMC9327159)

Pagnesi, M. et al. (2022) Clinical impact of changes in mitral regurgitation severity after medical therapy optimization in heart failure. Clinical Research in Cardiology, 111(8), pp. 912-923. (doi: 10.1007/s00392-022-01991-7) (PMID:35294624)

Pellicori, P. and Cleland, J. G. F. (2022) Heart failure: age is no excuse for complacency. European Journal of Heart Failure, 24(6), pp. 1063-1065. (doi: 10.1002/ejhf.2517) (PMID:35481861)

Pellicori, P. , McConnachie, A. , Carlin, C., Wales, A. and Cleland, J. G.F. (2022) Predicting mortality after hospitalisation for COPD using electronic health records. Pharmacological Research, 179, 106199. (doi: 10.1016/j.phrs.2022.106199) (PMID:35381341)

Pellicori, P. , Vaduganathan, M., Ferreira, J. P., Zannad, F. and Sanyal, A. J. (2022) Cross-talk between non-alcoholic fatty liver disease and cardiovascular disease: implications for future trial design. Diabetes and Metabolism, 48(2), 101281. (doi: 10.1016/j.diabet.2021.101281) (PMID:34543735)

Pugliese, N. R., Pellicori, P. , Filidei, F., De Biase, N., Maffia, P. , Guzik, T. J., Masi, S., Taddei, S. and Cleland, J. G.F. (2022) Inflammatory pathways in heart failure with preserved left ventricular ejection fraction: implications for future interventions. Cardiovascular Research, 118(18), pp. 3536-3555. (doi: 10.1093/cvr/cvac133) (PMID:36004819) (PMCID:PMC9897694)

Rao, S., Li, Y., Ramakrishnan, R., Hassaine, A., Canoy, D., Cleland, J. G. , Lukasiewicz, T., Salimi-Khorshidi, G. and Rahimi, K. (2022) An explainable transformer-based deep learning model for the prediction of incident heart failure. IEEE Journal of Biomedical and Health Informatics, 26(7), pp. 3362-3372. (doi: 10.1109/JBHI.2022.3148820) (PMID:35130176)

Rastogi, T., Bozec, E., Pellicori, P. , Bayes Genis, A., Coiro, S., Domingo, M., Gargani, L., Palazzuoli, A. and Girerd, N. (2022) Prognostic value and therapeutic utility of lung ultrasound in acute and chronic heart failure: a meta-analysis. JACC: Cardiovascular Imaging, 15(5), pp. 950-952. (doi: 10.1016/j.jcmg.2021.11.024) (PMID:35033496)

Rastogi, T. et al. (2022) Comparing and contrasting risk factors for heart failure in patients with and without history of myocardial infarction: data from HOMAGE and the UK Biobank. European Journal of Heart Failure, 24(6), pp. 976-984. (doi: 10.1002/ejhf.2495) (PMID:35365899) (PMCID:PMC9542039)

Ravassa, S. et al. (2022) Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial. European Journal of Heart Failure, 24(2), pp. 321-331. (doi: 10.1002/ejhf.2394) (PMID:34841615)

Ravera, A. et al. (2022) Distinct pathophysiological pathways in women and men with heart failure. European Journal of Heart Failure, 24(9), pp. 1532-1544. (doi: 10.1002/ejhf.2534) (PMID:35596674)

Rodríguez-Gómez, I. et al. (2022) Osteoporosis and its association with cardiovascular disease, respiratory disease, and cancer: findings from the UK Biobank prospective cohort study. Mayo Clinic Proceedings, 97(1), pp. 110-121. (doi: 10.1016/j.mayocp.2021.07.019) (PMID:34996542)

Romaine, S. P. R. et al. (2022) Telomere length is independently associated with all-cause mortality in chronic heart failure. Heart, 108(2), pp. 124-129. (doi: 10.1136/heartjnl-2020-318654) (PMID:33789973)

Rossignol, P. et al. (2022) Pragmatic diagnostic and therapeutic algorithms to optimize new potassium binder use in cardiorenal disease. Pharmacological Research, 182, 106277. (doi: 10.1016/j.phrs.2022.106277) (PMID:35662631)

Ryan, M., Morgan, H., Chiribiri, A., Nagel, E., Cleland, J. and Perera, D. (2022) Myocardial viability testing: all STICHed up, or about to be REVIVED? European Heart Journal, 43(2), pp. 118-126. (doi: 10.1093/eurheartj/ehab729) (PMID:34791132) (PMCID:PMC8757581)

Santema, B. T. et al. (2022) Pathophysiological pathways in patients with heart failure and atrial fibrillation. Cardiovascular Research, 118(11), pp. 2478-2487. (doi: 10.1093/cvr/cvab331) (PMID:34687289) (PMCID:PMC9400416)

Savarese, G. et al. (2022) Biomarker changes as surrogate endpoints in early‐phase trials in heart failure with reduced ejection fraction. ESC Heart Failure, 9(4), pp. 2107-2118. (doi: 10.1002/ehf2.13917) (PMID:35388650) (PMCID:PMC9288797)

Shi, T. et al. (2022) Risk of COVID-19 hospitalizations among school-aged children in Scotland: a national incident cohort study. Journal of Global Health, 12, 05044. (doi: 10.7189/jogh.12.05044) (PMID:36134546) (PMCID:PMC9494196)

Siland, J. E. et al. (2022) Resting heart rate and incident atrial fibrillation: A stratified Mendelian randomization in the AFGen consortium. PLoS ONE, 17(5), e0268768. (doi: 10.1371/journal.pone.0268768) (PMID:35594314) (PMCID:PMC9122202)

Stallard, S., Savioli, F., McConnachie, A. , Norrie, J., Dudman, K. , Morrow, E. S. and Romics, L. (2022) Antibiotic prophylaxis in breast cancer surgery (PAUS trial): randomised clinical double-blind parallel-group multicentre superiority trial. British Journal of Surgery, 109(12), pp. 1224-1231. (doi: 10.1093/bjs/znac280) (PMID:35932230)

Streng, K. W. et al. (2022) Clinical implications of low estimated protein intake in patients with heart failure. Journal of Cachexia, Sarcopenia and Muscle, 13(3), pp. 1762-1770. (doi: 10.1002/jcsm.12973) (PMID:35426256) (PMCID:PMC9178387)

Sullivan, M. K. et al. (2022) The presence and impact of multimorbidity clusters on adverse outcomes across the spectrum of kidney function. BMC Medicine, 20, 420. (doi: 10.1186/s12916-022-02628-2) (PMID:36320059) (PMCID:PMC9623942)

Sundaram, V. et al. (2022) Hospitalization for heart failure in the USA, UK, Taiwan and Japan: an international comparison of administrative health records on 417,385 individual patients. Journal of Cardiac Failure, 28(3), pp. 353-366. (doi: 10.1016/j.cardfail.2021.08.024) (PMID:34634448)

Täger, T., Frankenstein, L., Atar, D., Agewall, S., Frey, N., Grundtvig, M., Clark, A. L., Cleland, J. G.F. and Fröhlich, H. (2022) Influence of receptor selectivity on benefits from SGLT2 inhibitors in patients with heart failure: a systematic review and head-to-head comparative efficacy network meta-analysis. Clinical Research in Cardiology, 111(4), pp. 428-439. (doi: 10.1007/s00392-021-01913-z) (PMID:34498169)

Tayal, U. et al. (2022) Moderate excess alcohol consumption and adverse cardiac remodelling in dilated cardiomyopathy. Heart, 108(8), pp. 619-625. (doi: 10.1136/heartjnl-2021-319418) (PMID:34380661)

Tayal, U. et al. (2022) Precision phenotyping of dilated cardiomyopathy using multidimensional data. Journal of the American College of Cardiology, 79(22), pp. 2219-2232. (doi: 10.1016/j.jacc.2022.03.375) (PMID:35654493) (PMCID:PMC9168440)

Taylor-Rowan, M. , McGuire, L. , Hafdi, M., Evans, J. , Stott, D. J. , Wetherall, K., Elliott, E., Drozdowska, B. and Quinn, T. J. (2022) Comparative validity of informant tools for assessing pre-stroke cognitive impairment. International Journal of Geriatric Psychiatry, 37(4), pp. 1-10. (doi: 10.1002/gps.5700) (PMID:35278006)

Thomas, R., Greef, B., McConnachie, A. , Stanley, B. and Williams, M. (2022) Dietary consumption of tea and the risk of prostate cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. British Journal of Nutrition, 128(4), pp. 653-658. (doi: 10.1017/S0007114521003664) (PMID:34511161)

Thomson, P. C. et al. (2022) An analysis of vascular access thrombosis events from the Proactive IV Iron Therapy in Hemodialysis Patients (PIVOTAL) trial. Kidney International Reports, 7(8), pp. 1793-1801. (doi: 10.1016/j.ekir.2022.05.008) (PMID:35967105) (PMCID:PMC9366296)

Timmis, A. et al. (2022) European Society of Cardiology: cardiovascular disease statistics 2021. European Heart Journal, 43(8), pp. 716-799. (doi: 10.1093/eurheartj/ehab892) (PMID:35016208)

Timmons, J. G. , Littlejohn, L., Boyle, J. G. and Petrie, J. R. (2022) Recent developments in adjunct therapies for type 1 diabetes. Expert Opinion on Investigational Drugs, 31(12), pp. 1311-1320. (doi: 10.1080/13543784.2022.2159806) (PMID:36655950)

Torabi, F. et al. (2022) Risk of thrombocytopenic, haemorrhagic and thromboembolic disorders following COVID-19 vaccination and positive test: a self-controlled case series analysis in Wales. Scientific Reports, 12, 16406. (doi: 10.1038/s41598-022-20118-6) (PMID:36180455) (PMCID:PMC9524320)

Tromp, J. et al. (2022) Regional differences in precipitating factors of hospitalization for acute heart failure: insights from the REPORT‐HF registry. European Journal of Heart Failure, 24(4), pp. 645-652. (doi: 10.1002/ejhf.2431) (PMID:35064730)

Tromp, J. et al. (2022) A global perspective of racial differences and outcomes in patients presenting with acute heart failure. American Heart Journal, 243, pp. 11-14. (doi: 10.1016/j.ahj.2021.09.001) (PMID:34516969)

Tromp, J. et al. (2022) Global disparities in prescription of guideline-recommended drugs for heart failure with reduced ejection fraction. European Heart Journal, 43(23), pp. 2224-2234. (doi: 10.1093/eurheartj/ehac103) (PMID:35393622)

Verdonschot, J. A.J. et al. (2022) The effect of spironolactone in patients with obesity at risk for heart failure: proteomic insights from the HOMAGE trial. Journal of Cardiac Failure, 28(5), pp. 778-786. (doi: 10.1016/j.cardfail.2021.12.005) (PMID:34933097)

Ward, L. , Cooper, S.-A. , Henderson, A. , Stanley, B. , Greenlaw, N. , Pacitti, C. and Cairns, D. (2022) A study on prescriptions contributing to the risk of high anticholinergic burden in adults with intellectual disabilities: retrospective record linkage study. Annals of General Psychiatry, 21, 41. (doi: 10.1186/s12991-022-00418-x) (PMID:36309752) (PMCID:PMC9617313)

Wickens, O., Rengarajan, S., Chinnadurai, R., Ford, I. , Macdougall, I. C., Kalra, P. A. and Sinha, S. (2022) The role of iron in calciphylaxis—a current review. Journal of Clinical Medicine, 11(19), 5779. (doi: 10.3390/jcm11195779) (PMID:36233647) (PMCID:PMC9570530)

Williams, C. , McClay, C.-A., Martinez, R., Morrison, J. , Haig, C. , Jones, R. and Farrand, P. (2022) Online Cognitive Behavioral Therapy (CBT) life skills program for depression: pilot randomized controlled trial. JMIR Formative Research, 6(2), e30489. (doi: 10.2196/30489) (PMID:35175203) (PMCID:PMC8895278)

Wright, C. M. , Haig, C. , Harjunmaa, U., Sivakanthan, H. and Cole, T. J. (2022) Assessing the optimal time interval between growth measurements using a combined data set of weights and heights from 5948 infants. Archives of Disease in Childhood, 107(4), pp. 341-345. (doi: 10.1136/archdischild-2021-322479) (PMID:34521634)

Yengo, L. et al. (2022) A saturated map of common genetic variants associated with human height. Nature Communications, 610, pp. 704-712. (doi: 10.1038/s41586-022-05275-y) (PMID:36224396) (PMCID:PMC9605867)

Young, W. J. et al. (2022) Genetic analyses of the electrocardiographic QT interval and its components identify additional loci and pathways. Nature Communications, 13, 5144. (doi: 10.1038/s41467-022-32821-z) (PMID:36050321) (PMCID:PMC9436946)

Zhang, R. , Mamza, J. B., Morris, T., Godfrey, G., Asselbergs, F. W., Denaxas, S., Hemingway, H. and Banerjee, A. (2022) Lifetime risk of cardiovascular-renal disease in type 2 diabetes: a population-based study in 473,399 individuals. BMC Medicine, 20, 63. (doi: 10.1186/s12916-022-02234-2) (PMID:35130878) (PMCID:PMC8822817)

Articles

Alexander, J., Langhorne, P. , Kidd, L. , Wu, O. , McConnachie, A. , van Wijck, F. and Dawson, J. (2021) SaeboGlove therapy for upper limb disability and severe hand impairment after stroke (SUSHI): study protocol for a randomised controlled trial. European Stroke Journal, 6(3), pp. 302-310. (doi: 10.1177/23969873211036586) (PMCID:PMC8564154)

Ambrosy, A. P., von Haehling, S., Kalra, P. R., Court, E., Bhandari, S., McDonagh, T. and Cleland, J. G.F. (2021) Safety and efficacy of intravenous ferric derisomaltose compared to iron sucrose for iron deficiency anemia in patients with chronic kidney disease with and without heart failure. American Journal of Cardiology, 152, pp. 138-145. (doi: 10.1016/j.amjcard.2021.04.042) (PMID:34162484)

Andersen, E. et al. (2021) Contributions of changes in physical activity, sedentary time, diet and body weight to changes in cardiometabolic risk. International Journal of Behavioral Nutrition and Physical Activity, 18, 166. (doi: 10.1186/s12966-021-01237-1)

Anderson, J. J. et al. (2021) Remote history of VTE is associated with severe COVID-19 in middle and older age: UK Biobank cohort study. Journal of Thrombosis and Haemostasis, 19(10), pp. 2533-2538. (doi: 10.1111/jth.15452) (PMID:34242477) (PMCID:PMC8420476)

Anderson, J. J. et al. (2021) Ethnic differences in prevalence of actionable HbA1c levels in UK Biobank: implications for screening. BMJ Open Diabetes Research and Care, 9(1), e002176. (doi: 10.1136/bmjdrc-2021-002176) (PMID:34353880) (PMCID:PMC8344314)

Askarieh, A., Morrison, I., Ross, K., McCowan, C. , Matthews, K., Kidd, B. and Heath, C. A. (2021) Medication adherence, utilization of healthcare services, and mortality of patients with epilepsy on opiate replacement therapy: a retrospective cohort study. Epilepsy and Behavior, 117, 107829. (doi: 10.1016/j.yebeh.2021.107829) (PMID:33621811)

Austin, R. C., Schoonhoven, L., Clancy, M., Richardson, A., Kalra, P. R. and May, C. R. (2021) Do chronic heart failure symptoms interact with burden of treatment? Qualitative literature systematic review. BMJ Open, 11(7), e047060. (doi: 10.1136/bmjopen-2020-047060) (PMID:34330858) (PMCID:PMC8327846)

Bekfani, T. et al. (2021) A current and future outlook on upcoming technologies in the remote monitoring of patients with heart failure. European Journal of Heart Failure, 23(1), pp. 175-185. (doi: 10.1002/ejhf.2033) (PMID:33111389)

Berry, C. et al. (2021) Post-COVID-19 illness trajectory: a multisystem investigation [Pre-print]. Research Square, (doi: 10.21203/rs.3.rs-1053331/v1)

Bistola, V. et al. (2021) Association between up-titration of medical therapy and total hospitalizations and mortality in patients with recent worsening heart failure across the ejection fraction spectrum. European Journal of Heart Failure, 23(7), pp. 1170-1181. (doi: 10.1002/ejhf.2219) (PMID:33998113)

Bos, M. M. et al. (2021) Investigating the relationships between unfavourable habitual sleep and metabolomic traits: evidence from multi-cohort multivariable regression and Mendelian randomization analyses. BMC Medicine, 19(1), p. 69. (doi: 10.1186/s12916-021-01939-0) (PMID:33731105) (PMCID:PMC7971964)

Bouabdallaoui, N. et al. (2021) Impact of smoking on cardiovascular outcomes in patients with stable coronary artery disease. European Journal of Preventive Cardiology, 28(13), pp. 1460-1466. (doi: 10.1177/2047487320918728) (PMID:32340463)

Brosnahan, N. , Leslie, W., McCombie, L., Barnes, A., Thom, G. , McConnachie, A. , Messow, C. M. , Sattar, N. , Taylor, R. and Lean, M. E.J. (2021) Brief formula low‐energy‐diet for relapse management during weight loss maintenance in the Diabetes Remission Clinical Trial (DiRECT). Journal of Human Nutrition and Dietetics, 34(3), pp. 472-479. (doi: 10.1111/jhn.12839) (PMID:33406285)

Castrichini, M., Nuzzi, V., Sinagra, G., Cleland, J. and Pellicori, P. (2021) Use of social media by cardiovascular health care professionals: is patient privacy respected? JACC: Cardiovascular Imaging, 14(8), pp. 1680-1682. (doi: 10.1016/j.jcmg.2021.02.012) (PMID:34023252)

Cleland, J. G.F. et al. (2021) The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart 'OMics' in AGEing (HOMAGE) randomized clinical trial. European Heart Journal, 42(6), pp. 684-696. (doi: 10.1093/eurheartj/ehaa758) (PMID:33215209) (PMCID:PMC7878013)

Cleland, J. G.F. and Pellicori, P. (2021) To master heart failure, first master congestion. Lancet, 398(10304), pp. 935-936. (doi: 10.1016/S0140-6736(21)01914-0) (PMID:34461039)

Cleland, J. G.F. , Pellicori, P. and González, A. (2021) A novel treatment for heart failure targets myocardial fibrosis. Nature Medicine, 27(8), pp. 1343-1344. (doi: 10.1038/s41591-021-01457-9) (PMID:34385705)

Cleland, J. G.F. et al. (2021) The struggle towards a universal definition of heart failure—how to proceed? European Heart Journal, 42(24), pp. 2331-2343. (doi: 10.1093/eurheartj/ehab082) (PMID:33791787)

Coats, A. J. et al. (2021) The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA), and European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC. European Heart Journal, 42(13), pp. 1254-1269. (doi: 10.1093/eurheartj/ehab086) (PMID:33734354) (PMCID:PMC8014526)

Curzen, N. et al. (2021) Fractional flow reserve derived from computed tomography coronary angiography in the assessment and management of stable chest pain: the FORECAST randomized trial. European Heart Journal, 42(37), pp. 3844-3852. (doi: 10.1093/eurheartj/ehab444) (PMID:34269376)

Cuthbert, J. J., Pellicori, P. , Flockton, R., Kallvikbacka-Bennett, A., Khan, J., Rigby, A. S., Girerd, N., Zannad, F., Cleland, J. G.F. and Clark, A. L. (2021) The prevalence and clinical associations of ultrasound measures of congestion in patients at risk of developing heart failure. European Journal of Heart Failure, 23(11), pp. 1831-1840. (doi: 10.1002/ejhf.2353) (PMID:34632680)

Dalal, H., Taylor, R. S. and Cleland, J. G. (2021) Correspondence to European Heart Journal—Quality of Care and Clinical Outcomes in response to paper by Thomas, M. et al. 2021: Predicting the EQ-5D from the Kansas City Cardiomyopathy Questionnaire (KCCQ) in patients with heart failures. European Heart Journal: Quality of Care and Clinical Outcomes, 7(4), e7. (doi: 10.1093/ehjqcco/qcab033) (PMID:33914892) (PMCID:PMC8294675)

Darmon, A. et al. (2021) Prevalence, incidence and prognostic implications of Left Bundle Branch Block in patients with chronic coronary syndromes (From the CLARIFY Registry). American Journal of Cardiology, 150, pp. 40-46. (doi: 10.1016/j.amjcard.2021.03.047) (PMID:34011435)

Darmon, A. et al. (2021) Use of risk scores to identify lower and higher risk subsets among COMPASS-eligible patients with chronic coronary syndromes. Insights from the CLARIFY registry. Clinical Cardiology, 44(1), pp. 58-65. (doi: 10.1002/clc.23505) (PMID:33274779)

Davison, B. A. et al. (2021) Is acute heart failure a distinctive disorder? An analysis from BIOSTAT‐CHF. European Journal of Heart Failure, 23(1), pp. 43-57. (doi: 10.1002/ejhf.2077) (PMID:33340221)

Desai, A. S. et al. (2021) Mode of death in patients with heart failure and preserved ejection fraction: insights from PARAGON-HF. Circulation: Heart Failure, 14(12), e008597. (doi: 10.1161/CIRCHEARTFAILURE.121.008597) (PMID:34807713)

Diaz-Navarro, R., Urrútia, G., Cleland, J. G.F. , Poloni, D., Villagran, F., Acosta-Dighero, R., Bangdiwala, S. I., Rada, G. and Madrid, E. (2021) Stem cell therapy for dilated cardiomyopathy. Cochrane Database of Systematic Reviews, 2021(7), CD013433. (doi: 10.1002/14651858.cd013433.pub2) (PMID:34286511)

Docherty, K. F. et al. (2021) The effect of neprilysin inhibition on left ventricular remodeling in patients with asymptomatic left ventricular systolic dysfunction late after myocardial infarction. Circulation, 144(3), pp. 199-209. (doi: 10.1161/CIRCULATIONAHA.121.054892) (PMID:33983794)

Docherty, K. F. et al. (2021) Rationale and methods of a randomized trial evaluating the effect of neprilysin inhibition on left ventricular remodelling. ESC Heart Failure, 8(1), pp. 129-138. (doi: 10.1002/ehf2.13137) (PMID:33305513) (PMCID:PMC7835504)

Emmens, J. E. et al. (2021) Impaired high-density lipoprotein function in patients with heart failure. Journal of the American Heart Association, 10(9), e019123. (doi: 10.1161/JAHA.120.019123) (PMID:33870728)

Felker, G. M. et al. (2021) Effects of a novel nitroxyl donor in acute heart failure: the STAND-UP AHF Study. JACC: Heart Failure, 9(2), pp. 146-157. (doi: 10.1016/j.jchf.2020.10.012) (PMID:33248986)

Ferreira, J. P. et al. (2021) Serum potassium and outcomes in heart failure with preserved ejection fraction: a post-hoc analysis of the PARAGON-HF trial. European Journal of Heart Failure, 23(5), pp. 776-784. (doi: 10.1002/ejhf.2134) (PMID:33609066)

Ferreira, J. P. et al. (2021) Heart failure re-hospitalizations and subsequent fatal events in coronary artery disease: insights from COMMANDER-HF, EPHESUS, and EXAMINE. Clinical Research in Cardiology, 110(10), pp. 1554-1563. (doi: 10.1007/s00392-021-01830-1) (PMID:33686472)

Ferreira, J. P. et al. (2021) Impact of geographic region on the COMMANDER-HF Trial. JACC: Heart Failure, 9(3), pp. 201-211. (doi: 10.1016/j.jchf.2020.11.007) (PMID:33549557)

Ferreira, J. P., Girerd, N., Rocca, H.-P. B.-L., Pellicori, P. , Cleland, J. G. , Rossignol, P. and Zannad, F. (2021) No influence of spironolactone on plasma concentrations of angiotensin-converting enzyme 2: Findings from the HOMAGE randomized trial = Pas d’influence de la spironolactone sur les concentrations plasmatiques de l’enzyme de conversion de l’angiotensine 2 : résultats de l’essai randomisé HOMAGE. Archives of Cardiovascular Diseases, 114(12), pp. 814-817. (doi: 10.1016/j.acvd.2021.10.003) (PMID:34772647) (PMCID:PMC8576594)

Ferreira, J. P., Lam, C. S. P., Anker, S. D., Mehra, M. R., van Veldhuisen, D. J., Byra, W. M., La Police, D. A., Cleland, J. G.F. , Greenberg, B. and Zannad, F. (2021) Plasma D‐dimer concentrations predicting stroke risk and rivaroxaban benefit in patients with heart failure and sinus rhythm: an analysis from the COMMANDER‐HF trial. European Journal of Heart Failure, 23(4), pp. 648-656. (doi: 10.1002/ejhf.2003) (PMID:32959502)

Ferreira, J. P. et al. (2021) Differences in biomarkers and molecular pathways according to age for patients with HFrEF. Cardiovascular Research, 117(10), pp. 2228-2236. (doi: 10.1093/cvr/cvaa279) (PMID:33002110)

Ferreira, J. P. et al. (2021) Proteomic and mechanistic analysis of spironolactone in patients at risk for HF. JACC: Heart Failure, 9(4), pp. 268-277. (doi: 10.1016/j.jchf.2020.11.010) (PMID:33549556)

Ford, I. et al. (2021) Simple risk models to predict cardiovascular death in patients with stable coronary artery disease. European Heart Journal: Quality of Care and Clinical Outcomes, 7(3), pp. 287-294. (doi: 10.1093/ehjqcco/qcz070) (PMID:31922541)

Gorecka, M. et al. (2021) Demographic, multi-morbidity and genetic impact on myocardial involvement and its recovery from COVID-19: protocol design of COVID-HEART—a UK, multicentre, observational study. Journal of Cardiovascular Magnetic Resonance, 23, 77. (doi: 10.1186/s12968-021-00752-1) (PMID:34112195) (PMCID:PMC8190746)

Graham, F. J., Pellicori, P. , Cleland, J. G.F. and Clark, A. L. (2021) Reply to the letter regarding the article 'Natural history and prognostic significance of iron deficiency and anaemia in ambulatory patients with chronic heart failure'. European Journal of Heart Failure, 23(10), pp. 1800-1801. (doi: 10.1002/ejhf.2304) (PMID:34263510)

Graham, F. J., Pellicori, P. , Ford, I. , Petrie, M. C. , Kalra, P. R. and Cleland, J. G.F. (2021) Intravenous iron for heart failure with evidence of iron deficiency: a meta-analysis of randomised trials. Clinical Research in Cardiology, 110(8), pp. 1299-1307. (doi: 10.1007/s00392-021-01837-8) (PMID:33755777)

Greenwood, S. A. et al. (2021) The PrEscription of intraDialytic exercise to improve quAlity of Life in patients with chronic kidney disease trial: study design and baseline data for a multicentre randomized controlled trial. Clinical Kidney Journal, 14(5), pp. 1345-1355. (doi: 10.1093/ckj/sfaa107) (PMID:33959264) (PMCID:PMC8087141)

Greenwood, S. A. et al. (2021) Randomized trial-PrEscription of intraDialytic exercise to improve quAlity of Life in patients receiving hemodialysis. Kidney International Reports, 6(8), pp. 2159-2170. (doi: 10.1016/j.ekir.2021.05.034) (PMID:34386665) (PMCID:PMC8343798)

Greenwood, S. A. et al. (2021) Exercise programme to improve quality of life for patients with end-stage kidney disease receiving haemodialysis: the PEDAL RCT. Health Technology Assessment, 25(40), (doi: 10.3310/hta25400) (PMID:34156335)

Gupta, P. et al. (2021) Non-adherence to heart failure medications predicts clinical outcomes: assessment in a single spot urine sample by liquid chromatography-tandem mass spectrometry (results of a prospective multicentre study). European Journal of Heart Failure, 23(7), pp. 1182-1190. (doi: 10.1002/ejhf.2160) (PMID:33759308)

Halliday, B. P. et al. (2021) Myocardial remodelling after withdrawing therapy for heart failure in patients with recovered dilated cardiomyopathy – insights from TRED‐HF. European Journal of Heart Failure, 23(2), pp. 293-301. (doi: 10.1002/ejhf.2063) (PMID:33225554)

Halliday, B. P. et al. (2021) Heart rate as a marker of relapse during withdrawal of therapy in recovered dilated cardiomyopathy. JACC: Heart Failure, 9(7), pp. 509-517. (doi: 10.1016/j.jchf.2021.03.010) (PMID:34119469) (PMCID:PMC8259664)

He, T. et al. (2021) Serum and urinary biomarkers of collagen type‐I turnover predict prognosis in patients with heart failure. Clinical and Translational Medicine, 11(1), e267. (doi: 10.1002/ctm2.267) (PMID:33463057) (PMCID:PMC7803349)

He, T. et al. (2021) Urinary peptides in heart failure: a link to molecular pathophysiology. European Journal of Heart Failure, 23(11), pp. 1875-1887. (doi: 10.1002/ejhf.2195) (PMID:33881206)

Heggie, R. et al. (2021) Stratified medicine using invasive coronary function testing in angina: a cost-effectiveness analysis of the British Heart Foundation CorMicA trial. International Journal of Cardiology, 337, pp. 44-51. (doi: 10.1016/j.ijcard.2021.05.016) (PMID:33992700)

Henderson, A. , Kinnear, D. , Fleming, M. , Stanley, B. , Greenlaw, N. , Young-Southward, G., Pell, J. P. and Cooper, S.-A. (2021) Antipsychotic and antidepressant prescribing for 704 297 children and young people with and without intellectual disabilities: record linkage study. British Journal of Psychiatry, 218(1), pp. 58-62. (doi: 10.1192/bjp.2020.232) (PMID:33541472)

Henderson, D. A.G., Atherton, I., McCowan, C. , Mercer, S. W. and Bailey, N. (2021) Linkage of national health and social care data: a cross-sectional study of multimorbidity and social care use in people aged over 65 years in Scotland. Age and Ageing, 50(1), pp. 176-182. (doi: 10.1093/ageing/afaa134) (PMID:32687158)

Hughes-Mccormack, L., Greenlaw, N. , Mcskimming, P., Mccowan, C. , Ross, K., Allan, L., Henderson, A. , Melville, C. , Morrison, J. and Cooper, S.-A. (2021) Changes over time in the management of long-term conditions in primary health-care for adults with intellectual disabilities, and the health-care inequalities gap. Journal of Applied Research in Intellectual Disabilities, 34(2), pp. 634-647. (doi: 10.1111/jar.12833) (PMID:33283349)

Idris, I., Zhang, R. , Mamza, J. B., Ford, M., Morris, T., Banerjee, A., Khunti, K. and Tulip Mark Greener, J. (2021) Lower risk of hospitalization for heart failure, kidney disease and death with sodium-glucose co-transporter-2 inhibitors compared with dipeptidyl peptidase-4 inhibitors in type 2 diabetes regardless of prior cardiovascular or kidney disease: a retrospective cohort study in UK primary care. Diabetes, Obesity and Metabolism, 23(10), pp. 2207-2214. (doi: 10.1111/dom.14437) (PMID:33973690) (PMCID:PMC8518855)

Jensen, M. et al. (2021) Polypharmacy, functional outcome, and treatment effect of intravenous alteplase for acute ischemic stroke. European Journal of Neurology, 28(2), pp. 532-539. (doi: 10.1111/ene.14566) (PMID:33015924)

Jeyam, A. et al. (2021) Erratum. Clinical impact of residual C-peptide secretion in type 1 diabetes on glycemia and microvascular complications. Diabetes Care 2021;44:390–398. Diabetes Care, 44(4), p. 1072. (doi: 10.2337/dc21-er04b) (PMID:33731365)

Jhund, P. S. et al. (2021) Heart failure hospitalization in adults receiving maintenance hemodialysis and effect of intravenous iron therapy: A report from PIVOTAL. JACC: Heart Failure, 9(7), pp. 518-527. (doi: 10.1016/j.jchf.2021.04.005) (PMID:34119470)

Jorbenadze, A., Fudim, M., Mahfoud, F., Adamson, P. B., Bekfani, T., Wachter, R., Sievert, H., Ponikowski, P. P., Cleland, J. G.F. and Anker, S. D. (2021) Extra-cardiac targets in the management of cardiometabolic disease: device-based therapies. ESC Heart Failure, 8(4), pp. 3327-3338. (doi: 10.1002/ehf2.13361) (PMID:34002946) (PMCID:PMC8318435)

Kobayashi, M. et al. (2021) Association between right-sided cardiac function and ultrasound-based pulmonary congestion on acutely decompensated heart failure findings from a pooled analysis of four cohort studies. Clinical Research in Cardiology, 110(8), pp. 1181-1192. (doi: 10.1007/s00392-020-01724-8) (PMID:32770373)

Lagou, V. et al. (2021) Sex-dimorphic genetic effects and novel loci for fasting glucose and insulin variability. Nature Communications, 12, 24. (doi: 10.1038/s41467-020-19366-9) (PMID:33402679) (PMCID:PMC7785747)

Lang, N. N. et al. (2021) Haemodynamic effects of the nitroxyl donor cimlanod (BMS-986231) in chronic heart failure: a randomized trial. European Journal of Heart Failure, 23(7), pp. 1147-1155. (doi: 10.1002/ejhf.2138) (PMID:33620131)

Lee, M. M.Y. et al. (2021) Effect of empagliflozin on left ventricular volumes in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF). Circulation, 143(6), pp. 516-525. (doi: 10.1161/CIRCULATIONAHA.120.052186) (PMID:33186500) (PMCID:PMC7864599)

Lee, M. M.Y. et al. (2021) Invasive versus medically managed acute coronary syndromes with prior bypass (CABG-ACS): insights into the registry versus randomised trial populations. Open Heart, 8(1), e001453. (doi: 10.1136/openhrt-2020-001453) (PMID:33637568) (PMCID:PMC7919592)

Lee, S. I. et al. (2021) Protocol for the development of a core outcome set for studies of pregnant women with pre-existing multimorbidity. BMJ Open, 11(10), e044919. (doi: 10.1136/bmjopen-2020-044919) (PMID:34716152) (PMCID:PMC8559099)

Leslie, W. S. et al. (2021) Antihypertensive medication needs and blood pressure control with weight loss in the Diabetes Remission Clinical Trial (DiRECT). Diabetologia, 64(9), pp. 1927-1938. (doi: 10.1007/s00125-021-05471-x) (PMID:34056684)

Lota, A. S. et al. (2021) Prognostic significance of nonischaemic myocardial fibrosis in patients with normal left ventricular volumes and ejection-fraction. JACC: Cardiovascular Imaging, 14(12), pp. 2353-2365. (doi: 10.1016/j.jcmg.2021.05.016) (PMID:34274268) (PMCID:PMC8648892)

Lumbers, R. T. et al. (2021) The genomics of heart failure: design and rationale of the HERMES consortium. ESC Heart Failure, 8(6), pp. 5531-5541. (doi: 10.1002/ehf2.13517) (PMID:34480422) (PMCID:PMC8712846)

MacDonald, T. M., Nuki, G., Robertson, M., Ford, I. and Mackenzie, I. S. (2021) Cardiovascular safety of febuxostat - Authors' reply. Lancet, 398(10304), pp. 955-956. (doi: 10.1016/S0140-6736(21)01383-0) (PMID:34509228)

Macfarlane, A. J.R. et al. (2021) Anaesthesia Choice for Creation of Arteriovenous Fistula (ACCess) study protocol: a randomised controlled trial comparing primary unassisted patency at 1 year of primary arteriovenous fistulae created under regional compared to local anaesthesia. BMJ Open, 11(12), e052188. (doi: 10.1136/bmjopen-2021-052188) (PMID:34937718) (PMCID:PMC8704953)

Macfarlane, P. W. and Kennedy, J. (2021) Automated ECG interpretation—a brief history from high expectations to deepest networks. Hearts, 2(4), pp. 433-448. (doi: 10.3390/hearts2040034)

Mackenzie, R. M. et al. (2021) SurgiCal Obesity Treatment Study (SCOTS): a prospective, observational cohort study on health and socioeconomic burden in treatment-seeking individuals with severe obesity in Scotland, UK. BMJ Open, 11(8), e046441. (doi: 10.1136/bmjopen-2020-046441) (PMID:34446484)

Maclean, L. M., McSkimming, P. and McMillan, T. M. (2021) The association between dual-task walking and counting responses and cognitive function and disability after severe head injury: a preliminary study. Neuropsychological Rehabilitation, 31(4), pp. 570-582. (doi: 10.1080/09602011.2020.1716812) (PMID:31989869)

Mak, K.-H. et al. (2021) Prevalence of diabetes and impact on cardiovascular events and mortality in patients with chronic coronary syndromes, across multiple geographical regions and ethnicities. European Journal of Preventive Cardiology, 28(16), pp. 1795-1806. (doi: 10.1093/eurjpc/zwab011) (PMID:35022686)

Mark, P. B. et al. (2021) Stroke in hemodialysis patients randomized to different intravenous iron strategies: a prespecified analysis from the PIVOTAL trial. Kidney360, 2(11), pp. 1761-1769. (doi: 10.34067/KID.0004272021)

Markousis-Mavrogenis, G. et al. (2021) The additive prognostic value of serial plasma interleukin-6 levels over changes in brain natriuretic peptide in patients with acute heart failure. Journal of Cardiac Failure, 27(7), pp. 808-811. (doi: 10.1016/j.cardfail.2021.01.008) (PMID:33497808)

Maznyczka, A. M. et al. (2021) Risk stratification guided by the index of microcirculatory resistance and left ventricular end-diastolic pressure in acute myocardial infarction. Circulation: Cardiovascular Interventions, 14(2), e009529. (doi: 10.1161/CIRCINTERVENTIONS.120.009529) (PMID:33591821)

Maznyczka, A. M. et al. (2021) Effect of coronary flow on intracoronary alteplase: a prespecified analysis from a randomised trial. Heart, 107(4), pp. 299-312. (doi: 10.1136/heartjnl-2020-317828) (PMID:33436493)

McCallum, L., Brooksbank, K., McConnachie, A. , Aman, A. , Lip, S. , Dawson, J. , MacIntyre, I. M., MacDonald, T. M., Webb, D. J. and Padmanabhan, S. (2021) Rationale and design of the genotype-blinded trial of torasemide for the treatment of hypertension (BHF UMOD). American Journal of Hypertension, 34(1), pp. 92-99. (doi: 10.1093/ajh/hpaa166) (PMID:33084880) (PMCID:PMC7891239)

McDonagh, T. A. et al. (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal, 42(36), pp. 3599-3726. (doi: 10.1093/eurheartj/ehab368) (PMID:34447992)

Meijers, W. C. et al. (2021) Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC). European Journal of Heart Failure, 23(10), pp. 1610-1632. (doi: 10.1002/ejhf.2346) (PMID:34498368)

Mesnier, J., Ducrocq, G., Danchin, N., Ferrari, R., Ford, I. , Tardif, J.-C., Tendera, M., Fox, K. M. and Steg, P. G. (2021) International observational analysis of evolution and outcomes of chronic stable angina: the multinational observational CLARIFY study. Circulation, 144(7), pp. 512-523. (doi: 10.1161/CIRCULATIONAHA.121.054567) (PMID:34261331)

Mitchell, K. R. et al. (2021) Feasibility study of peer-led and school-based social network Intervention (STASH) to promote adolescent sexual health. Pilot and Feasibility Studies, 7, 125. (doi: 10.1186/s40814-021-00835-x) (PMID:34127082) (PMCID:PMC8201683)

Mordi, I. R. et al. (2021) Heart failure treatment up-titration and outcome and age: an analysis of BIOSTAT-CHF. European Journal of Heart Failure, 23(3), pp. 436-444. (doi: 10.1002/ejhf.1799) (PMID:32216000)

Mutambudzi, M. et al. (2021) Occupation and risk of severe COVID-19: prospective cohort study of 120 075 UK Biobank participants. Occupational and Environmental Medicine, 78(5), pp. 307-314. (doi: 10.1136/oemed-2020-106731) (PMID:33298533)

Nkoka, O. , Chuang, T.-W. and Chen, Y.-H. (2021) Influence of maternal exposure to malaria social and behavioral change messages and effectiveness of communication media on bed net use and malaria infection in Malawi. Health Education and Behavior, 48(2), pp. 179-189. (doi: 10.1177/1090198120964201) (PMID:33095066)

Nkoka, O. , Lee, D., Chuang, K.-Y. and Chuang, Y.-C. (2021) Multilevel analysis of the role of women's empowerment on use of contraceptive methods among married Cambodian women: evidence from demographic health surveys between 2005 and 2014. BMC Women's Health, 21(1), 9. (doi: 10.1186/s12905-020-01141-z) (PMID:33407398) (PMCID:PMC7789707)

Ntenda, P. A. M. et al. (2021) Determinants of self-reported correct knowledge about tuberculosis transmission among men and women in Malawi: evidence from a nationwide household survey. BMC Infectious Diseases, 21, 132. (doi: 10.1186/s12879-021-05836-y) (PMID:33516174) (PMCID:PMC7847566)

Pagnesi, M. et al. (2021) Impact of mitral regurgitation in patients with worsening heart failure: insights from BIOSTAT-CHF. European Journal of Heart Failure, 23(10), pp. 1750-1758. (doi: 10.1002/ejhf.2276) (PMID:34164895)

Paixão, G. M. M., Lima, E. M., Gomes, P. R., Oliveira, D. M., Ribeiro, M. H., Nascimento, J. S., Ribeiro, A. H., Macfarlane, P. W. and Ribeiro, A. L. P. (2021) Electrocardiographic predictors of mortality: data from a primary care tele-electrocardiography cohort of Brazilian patients. Hearts, 2(4), pp. 449-458. (doi: 10.3390/hearts2040035)

Pan, D. et al. (2021) Prognostic value of the chest x-ray in patients hospitalised for heart failure. Clinical Research in Cardiology, 110(11), pp. 1743-1756. (doi: 10.1007/s00392-021-01836-9) (PMID:33754159)

Pandhi, P. et al. (2021) The value of spot urinary creatinine as a marker of muscle wasting in patients with new-onset or worsening heart failure. Journal of Cachexia, Sarcopenia and Muscle, 12(3), pp. 555-567. (doi: 10.1002/jcsm.12690) (PMID:33742549)

Papageorgiou, V., Jones, K., Halliday, B. P., Mindham, R., Bruton, J., Wassall, R., Cleland, J. G.F. , Prasad, S. K. and Ward, H. (2021) A qualitative exploration of participant and investigator perspectives from the TRED-HF trial. ESC Heart Failure, 8(5), pp. 3760-3768. (doi: 10.1002/ehf2.13524) (PMID:34390213) (PMCID:PMC8497205)

Pellicori, P. and Cleland, J. G.F. (2021) Structural heart disease, cardiac dysfunction and heart failure: the ambiguity of a definition. European Journal of Preventive Cardiology, 28(9), pp. 921-923. (doi: 10.1177/2047487320937135) (PMID:32718235)

Pellicori, P. et al. (2021) COVID-19 and its cardiovascular effects: a systematic review of prevalence studies. Cochrane Database of Systematic Reviews, 2021(3), CD013879. (doi: 10.1002/14651858.CD013879) (PMID:33704775)

Pellicori, P. et al. (2021) Use of diuretics and outcomes in patients with type 2 diabetes: findings from the EMPA-REG OUTCOME trial. European Journal of Heart Failure, 23(7), pp. 1085-1093. (doi: 10.1002/ejhf.2220) (PMID:34031968)

Pellicori, P. et al. (2021) Ultrasound imaging of congestion in heart failure – examinations beyond the heart. European Journal of Heart Failure, 23(5), pp. 703-712. (doi: 10.1002/ejhf.2032) (PMID:33118672)

Raafs, A. et al. (2021) Identification of sex‐specific biomarkers predicting new‐onset heart failure. ESC Heart Failure, 8(5), pp. 3512-3520. (doi: 10.1002/ehf2.13476) (PMID:34156155) (PMCID:PMC8497379)

Rubel, P., Fayn, J., Macfarlane, P. W., Pani, D., Schlögl, A. and Värri, A. (2021) The history and challenges of SCP-ECG: the standard communication protocol for computer-assisted electrocardiography. Hearts, 2(3), pp. 384-409. (doi: 10.3390/hearts2030031)

Rush, C. J., Cleland, J. G.F. and Veldtman, G. (2021) The emerging burden of heart failure in adults with congenital heart disease. International Journal of Cardiology Congenital Heart Disease, 4, 100171. (doi: 10.1016/j.ijcchd.2021.100171)

Samuel, N. A., Cuthbert, J. J., Brown, O. I., Kazmi, S., Cleland, J. G.F. , Rigby, A. S. and Clark, A. L. (2021) Relation between thyroid function and mortality in patients with chronic heart failure. American Journal of Cardiology, 139, pp. 57-63. (doi: 10.1016/j.amjcard.2020.10.034) (PMID:33115640)

Schnabel, S. et al. (2021) Experiences of augmented arm rehabilitation including supported self-management after stroke: a qualitative investigation. Clinical Rehabilitation, 35(2), pp. 288-301. (doi: 10.1177/0269215520956388) (PMID:32907393)

Schunk, S. J. et al. (2021) Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality. European Heart Journal, 42(18), pp. 1742-1756. (doi: 10.1093/eurheartj/ehab107) (PMID:33748830)

Shah, P., Abel, A. A.I., Boyalla, V., Pellicori, P. , Kallvikbacka-Bennett, A., Sze, S., Cleland, J. G.F. and Clark, A. L. (2021) A comparison of non-invasive methods of measuring body composition in patients with heart failure: a report from SICA-HF. ESC Heart Failure, 8(5), pp. 3929-3934. (doi: 10.1002/ehf2.13402) (PMID:34216106) (PMCID:PMC8497207)

Shah, P., Pellicori, P. , Hanning, I., Zhang, J., Clark, A. L. and Bhandari, S. (2021) The effect of digoxin on renal function in patients with heart failure. BMC Nephrology, 22(1), 349. (doi: 10.1186/s12882-021-02562-0) (PMCID:PMC8549227)

Sharma, S. et al. (2021) Periodontal therapy and treatment of hypertension – alternative to the pharmacological approach. A systematic review and meta-analysis. Pharmacological Research, 166, 105511. (doi: 10.1016/j.phrs.2021.105511) (PMID:33617973)

Shoaib, A. et al. (2021) Substantial decline in hospital admissions for heart failure accompanied by increased community mortality during COVID-19 pandemic. European Heart Journal: Quality of Care and Clinical Outcomes, 7(4), pp. 378-387. (doi: 10.1093/ehjqcco/qcab040) (PMID:34043762) (PMCID:PMC8244536)

Sierpinski, R. et al. (2021) High soluble transferrin receptor in patients with heart failure: a measure of iron deficiency and a strong predictor of mortality. European Journal of Heart Failure, 23(6), pp. 919-932. (doi: 10.1002/ejhf.2036) (PMID:33111457)

Simpson, J. et al. (2021) Adherence to prescribed medications in patients with heart failure – insights from liquid chromatography-tandem mass spectrometry-based urine analysis. European Heart Journal: Cardiovascular Pharmacotherapy, 7(4), pp. 296-301. (doi: 10.1093/ehjcvp/pvaa071) (PMID:32597982) (PMCID:PMC8302254)

Smart, N. A., Pearson, M. J., Taylor, R. S. and Cleland, J. (2021) Exercise training for heart failure with preserved ejection fraction (ExTraMATCH III): protocol for an individual patient data meta-analysis. Journal of Clinical Exercise Physiology, 10(1), pp. 3-11. (doi: 10.31189/2165-7629-10.1.3)

Sullivan, F. et al. (2021) Earlier diagnosis of lung cancer in a randomised trial of an autoantibody blood test followed by imaging. European Respiratory Journal, 57(1), 2000670. (doi: 10.1183/13993003.00670-2020) (PMID:32732334)

Sullivan, M. K. et al. (2021) Multimorbidity and the risk of major adverse kidney events: findings from the UK Biobank cohort. Clinical Kidney Journal, 14(11), pp. 2409-2419. (doi: 10.1093/ckj/sfab079) (PMCID:PMC8573008)

Sullivan, M. K. et al. (2021) Hospitalisation events in people with chronic kidney disease as a component of multimorbidity: parallel cohort studies in research and routine care settings. BMC Medicine, 19, 278. (doi: 10.1186/s12916-021-02147-6)

Sze, S., Pellicori, P. , Zhang, J., Weston, J. and Clark, A. L. (2021) The impact of malnutrition on short-term morbidity and mortality in ambulatory patients with heart failure. American Journal of Clinical Nutrition, 113(3), pp. 695-705. (doi: 10.1093/ajcn/nqaa311) (PMID:33236050)

Täger, T., Atar, D., Agewall, S., Katus, H. A., Grundtvig, M., Cleland, J. G.F. , Clark, A. L., Fröhlich, H. and Frankenstein, L. (2021) Comparative efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) for cardiovascular outcomes in type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials. Heart Failure Reviews, 26(6), pp. 1421-1435. (doi: 10.1007/s10741-020-09954-8) (PMID:32314085) (PMCID:PMC8510986)

Teerlink, J. R. et al. (2021) Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure. New England Journal of Medicine, 384, pp. 105-116. (doi: 10.1056/NEJMoa2025797) (PMID:33185990)

Thom, G. et al. (2021) Predictors of type 2 diabetes in the Diabetes Remission Clinical Trial (DiRECT). Diabetic Medicine, 38(8), e14395. (doi: 10.1111/dme.14395) (PMID:32870520)

Thom, G. et al. (2021) Weight loss induced increase in fasting ghrelin concentration is a predictor of weight regain: evidence from the Diabetes Remission Clinical Trial. Diabetes, Obesity and Metabolism, 23(3), pp. 711-719. (doi: 10.1111/dom.14274) (PMID:33369058)

Timmons, J. G. et al. (2021) Metformin and carotid intima-media thickness in never-smokers with type 1 diabetes: the REMOVAL trial. Diabetes, Obesity and Metabolism, 23(6), pp. 1371-1378. (doi: 10.1111/dom.14350) (PMID:33591613)

Tromp, J. et al. (2021) Global differences in burden and treatment of ischemic heart disease in acute heart failure: REPORT-HF. JACC: Heart Failure, 9(5), pp. 349-359. (doi: 10.1016/j.jchf.2020.12.015) (PMID:33839078)

Uijl, A., Vaartjes, I., Denaxas, S., Hemingway, H., Shah, A. D., Cleland, J. , Grobbee, D. E., Hoes, A. W., Asselbergs, F. W. and Koudstaal, S. (2021) Temporal trends in heart failure medication prescription in a population-based cohort study. BMJ Open, 11(3), e043290. (doi: 10.1136/bmjopen-2020-043290) (PMID:33653753) (PMCID:PMC7929882)

Verdonschot, J. A.J. et al. (2021) Proteomic mechanistic profile of patients with diabetes at risk of developing heart failure: insights from the HOMAGE trial. Cardiovascular Diabetology, 20, 163. (doi: 10.1186/s12933-021-01357-9)

Ward, L. M. , Stanley, B. , Greenlaw, N. , Cooper, S.-A. , Pacitti, C., Henderson, A. , Gibson, J. and Kinnear, D. (2021) Risk of anticholinergic burden in adults with intellectual disabilities: a Scottish retrospective cohort study of n = 17 220. Journal of Intellectual Disability Research, 65(9), pp. 813-830. (doi: 10.1111/jir.12861) (PMID:34169610)

Willder, J. M., McCall, P. , Messow, C.-M. , Gillies, M., Berry, C. and Shelley, B. (2021) Study protocol for COVID-RV: a multicentre prospective observational cohort study of right ventricular dysfunction in ventilated patients with COVID-19. BMJ Open, 11(1), e042098. (doi: 10.1136/bmjopen-2020-042098) (PMID:33441361) (PMCID:PMC7811959)

Williamson, A. E. , McQueenie, R., Ellis, D. A., McConnachie, A. and Wilson, P. (2021) ‘Missingness’ in health care: Associations between hospital utilization and missed appointments in general practice. A retrospective cohort study. PLoS ONE, 16(6), e0253163. (doi: 10.1371/journal.pone.0253163) (PMID:34166424) (PMCID:PMC8224850)

Wolsk, E. et al. (2021) Determinants and consequences of heart rate and stroke volume response to exercise in patients with heart failure and preserved ejection fraction. European Journal of Heart Failure, 23(5), pp. 754-764. (doi: 10.1002/ejhf.2146) (PMID:33686716)

Young, B., Kotzur, M. , Gatting, L., Bonner, C., Ayre, J., McConnachie, A. , Batcup, C., McCaffery, K., O'Carroll, R. and Robb, K. A. (2021) The impact of theory-based messages on COVID-19 vaccination intentions: a structured summary of a study protocol for a randomised controlled trial. Trials, 22, 311. (doi: 10.1186/s13063-021-05277-7) (PMID:33926540) (PMCID:PMC8082050)

Zakeri, R., Morgan, A. D., Sundaram, V., Bloom, C., Cleland, J. G.F. and Quint, J. K. (2021) Under-recognition of heart failure in patients with atrial fibrillation and the impact of gender: a UK population-based cohort study. BMC Medicine, 19, 179. (doi: 10.1186/s12916-021-02048-8) (PMID:34372832) (PMCID:PMC8353868)

Zhang, J., Pellicori, P. , Schutte, R. and Cleland, J.G. (2021) The association between blood groups and COVID-19 infection: a study from the UK Biobank. Journal of Internal Medicine, 289(5), pp. 747-748. (doi: 10.1111/joim.13226) (PMID:33306225)

Conference or Workshop Item

Morrow, A. et al. (2021) Rationale and design of the Medical Research Council Precision medicine with Zibotentan in microvascular angina (PRIZE) trial MRI sub-study. British Society of Cardiovascular Magnetic Resonance 2021 Annual Meeting, 12 October 2021. A2.1-A2. (doi: 10.1136/heartjnl-2021-BSCMR.3)

Ward, L. , Cooper, S.-A. , Stanley, B. , Greenlaw, N. , Pacitti, C., Henderson, A. , Pell, J. and Kinnear, D. (2021) Dental Experiences of Adults With Intellectual Disabilities: a Record Linkage Study of n=17,220. 6th IASSIDD Europe Congress, 06-08 Jul 2021.

Articles

Al-Mrabeh, A., Hollingsworth, K. G., Shaw, J. A.M., McConnachie, A. , Sattar, N. , Lean, M. E.J. and Taylor, R. (2020) 2-year remission of type 2 diabetes and pancreas morphology: a post-hoc analysis of the DiRECT open-label, cluster-randomised trial. Lancet Diabetes and Endocrinology, 8(12), pp. 939-948. (doi: 10.1016/S2213-8587(20)30303-X) (PMID:33031736)

Anker, M. S., Hülsmann, M. and Cleland, J. G. (2020) What do patients with heart failure die from? A single assassin or a conspiracy? European Journal of Heart Failure, 22(1), pp. 26-28. (doi: 10.1002/ejhf.1689) (PMID:31863684)

Anker, S. D. et al. (2020) Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an expert consensus position paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). European Heart Journal, 41(22), pp. 2109-2117. (doi: 10.1093/eurheartj/ehaa461) (PMID:32498081)

Atmadani, R. N., Nkoka, O. , Yunita, S. L. and Chen, Y.-H. (2020) Self-medication and knowledge among pregnant women attending primary healthcare services in Malang, Indonesia: a cross-sectional study. BMC Pregnancy and Childbirth, 20, 42. (doi: 10.1186/s12884-020-2736-2) (PMID:31948428) (PMCID:PMC6966862)

Austin, R. C., Schoonhoven, L., Richardson, A., Kalra, P. R. and May, C. R. (2020) How do SYMPtoms and management tasks in chronic heart failure imPACT a person's life (SYMPACT)? Protocol for a mixed-methods study. ESC Heart Failure, 7(6), pp. 4472-4477. (doi: 10.1002/ehf2.13010) (PMID:32940966) (PMCID:PMC7754908)

Barow, E. et al. (2020) Clinical characteristics and outcome of patients with lacunar infarcts and concurrent embolic ischemic lesions. Clinical Neuroradiology, 30, pp. 511-516. (doi: 10.1007/s00062-019-00800-5) (PMID:1161343)

Baylan, S. et al. (2020) Measuring the Effects of Listening for Leisure on Outcome after stroke (MELLO): a pilot randomised controlled trial of mindful music listening. International Journal of Stroke, 15(2), pp. 149-158. (doi: 10.1177/1747493019841250) (PMID:30940047) (PMCID:PMC7045280)

Bégué, C. et al. (2020) Mid-regional proatrial natriuretic peptide for predicting prognosis in hypertrophic cardiomyopathy. Heart, 106(3), pp. 196-202. (doi: 10.1136/heartjnl-2019-314826) (PMID:31350276)

Biscaglia, S. et al. (2020) Relationship between physical activity and long-term outcomes in patients with stable coronary artery disease. European Journal of Preventive Cardiology, 27(4), pp. 426-436. (doi: 10.1177/2047487319871217) (PMID:31558054)

Bivard, A. et al. (2020) Comparing mismatch strategies for patients being considered for ischemic stroke tenecteplase trials. International Journal of Stroke, 15(5), pp. 507-515. (doi: 10.1177/1747493019884529) (PMID:31684841)

Bomer, N. et al. (2020) Selenium and outcome in heart failure. European Journal of Heart Failure, 22(8), pp. 1415-1423. (doi: 10.1002/ejhf.1644) (PMID:31808274) (PMCID:PMC7540257)

Brown, O., Costanzo, P., Clark, A. L., Condorelli, G., Cleland, J. G.F. , Sathyapalan, T., Hepburn, D., Kilpatrick, E. S. and Atkin, S. L. (2020) Relationship between a single measurement at baseline of body mass index, glycated hemoglobin, and the risk of mortality and cardiovascular morbidity in type 2 diabetes mellitus. Cardiovascular Endocrinology and Metabolism, 9(4), pp. 177-182. (doi: 10.1097/XCE.0000000000000202) (PMID:33225234) (PMCID:PMC7673766)

Bulluck, H. et al. (2020) Redefining adverse and reverse left ventricular remodeling by cardiovascular magnetic resonance following ST-segment elevation myocardial infarction and their implications on long-term prognosis. Circulation: Cardiovascular Imaging, 13(7), e009937. (doi: 10.1161/CIRCIMAGING.119.009937) (PMID:32689822)

Campbell, R. T. et al. (2020) The novel urinary proteomic classifier HF1 has similar diagnostic and prognostic utility to BNP in heart failure. ESC Heart Failure, 7(4), pp. 1595-1604. (doi: 10.1002/ehf2.12708) (PMID:32383555) (PMCID:PMC7373887)

Cao, T. H. et al. (2020) Plasma proteomic approach in patients with heart failure: insights into pathogenesis of disease progression and potential novel treatment targets. European Journal of Heart Failure, 22(1), pp. 70-80. (doi: 10.1002/ejhf.1608) (PMID:31692186) (PMCID:PMC7028019)

Chen, S. et al. (2020) Associations of cytomegalovirus infection with all-cause and cardiovascular mortality in multiple observational cohort studies of older adults. Journal of Infectious Diseases, (doi: 10.1093/infdis/jiaa480) (PMID:32909605)

Chuang, Y.-C., Chuang, T.-W., Chao, H. J., Tseng, K.-C., Nkoka, O. , Sunaringsih, S. and Chuang, K.-Y. (2020) Contextual factors and spatial patterns of childhood malnutrition in provinces of Burkina Faso. Journal of Tropical Pediatrics, 66(1), pp. 66-74. (doi: 10.1093/tropej/fmz031) (PMID:31086979)

Cleland, J. G.F. , Clark, R. A., Pellicori, P. and Inglis, S. C. (2020) Caring for people with heart failure and many other medical problems through and beyond the COVID‐19 pandemic; the advantages of universal‐access to home telemonitoring. European Journal of Heart Failure, 22(6), pp. 995-998. (doi: 10.1002/ejhf.1864) (PMID:32385954) (PMCID:PMC7273055)

Cleland, J. G.F. , Li, C. and Jones, Y. (2020) Artificial intelligence needs clinical intelligence to succeed. JACC: Heart Failure, 8(7), pp. 588-591. (doi: 10.1016/j.jchf.2020.06.002) (PMID:32616167)

Cleland, J. G.F. , Lyon, A. R., McDonagh, T. and McMurray, J. J.V. (2020) The year in cardiology 2019: heart failure. Romanian Journal of Cardiology, 30(2), pp. 185-204. (doi: 10.47803/rjc.2020.30.2.185)

Cleland, J. G.F. , Lyon, A. R., McDonagh, T. and McMurray, J. J.V. (2020) The year in cardiology: heart failure. European Heart Journal, 41(12), pp. 1232-1248. (doi: 10.1093/eurheartj/ehz949) (PMID:31901936) (PMCID:PMC7084174)

Cooper, S.-A. , Allan, L., Greenlaw, N. , McSkimming, P., Jasilek, A., Henderson, A. , McCowan, C. , Kinnear, D. and Melville, C. (2020) Rates, causes, place, and predictors of mortality in adults with intellectual disabilities with and without Down syndrome: cohort study with record linkage. BMJ Open, 10, e03646. (doi: 10.1136/bmjopen-2019-036465) (PMID:32423940) (PMCID:PMC7239521)

Cunningham, J. W. et al. (2020) Natriuretic peptide-based inclusion criteria in a heart failure clinical trial: insights from COMMANDER HF. JACC: Heart Failure, 8(5), pp. 359-368. (doi: 10.1016/j.jchf.2019.12.009) (PMID:32171760) (PMCID:PMC7151428)

de Montmollin, M. et al. (2020) L-thyroxine therapy for older adults with subclinical hypothyroidism and hypothyroid symptoms: secondary analysis of a randomized trial. Annals of Internal Medicine, 172(11), pp. 709-716. (doi: 10.7326/M19-3193) (PMID:32365355)

Erzurumluoglu, A. M. et al. (2020) Meta-analysis of up to 622,409 individuals identifies 40 novel smoking behaviour associated genetic loci. Molecular Psychiatry, 25(10), pp. 2392-2409. (doi: 10.1038/s41380-018-0313-0) (PMID:30617275) (PMCID:PMC7515840)

Felker, G. M., Solomon, S. D., McMurray, J. J.V. , Cleland, J. G.F. , Abbasi, S. A., Malik, F. I., Zhang, H., Globe, G. and Teerlink, J. R. (2020) Effects of omecamtiv mecarbil on symptoms and health-related quality of life in patients with chronic heart failure: results from the COSMIC-HF study. Circulation: Heart Failure, 13(12), e007814. (doi: 10.1161/CIRCHEARTFAILURE.120.007814) (PMID:33176437) (PMCID:PMC7742205)

Ferrari, R., Ford, I. , Fox, K., Challeton, J. P., Correges, A., Tendera, M., Widimský, P. and Danchin, N. (2020) Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial. Lancet, 396(10254), pp. 830-838. (doi: 10.1016/S0140-6736(20)31790-6) (PMID:32877651)

Ferreira, J. P. et al. (2020) Cardiovascular and non‐cardiovascular death distinction: the utility of troponin beyond N‐terminal pro‐B‐type natriuretic peptide. Findings from the BIOSTAT‐CHF study. European Journal of Heart Failure, 22(1), pp. 81-89. (doi: 10.1002/ejhf.1654) (PMID:31793144)

Filippatos, G. et al. (2020) Global differences in characteristics, precipitants, and initial management of patients presenting with acute heart failure. JAMA Cardiology, 5(4), pp. 401-410. (doi: 10.1001/jamacardio.2019.5108) (PMID:31913404)

Ford, T. J. et al. (2020) 1-year outcomes of angina management guided by invasive coronary function testing (CorMicA). JACC: Cardiovascular Interventions, 13(1), pp. 33-45. (doi: 10.1016/j.jcin.2019.11.001) (PMID:31709984)

Frey, B. M. et al. (2020) Safety and efficacy of intravenous thrombolysis in stroke patients on prior antiplatelet therapy in the WAKE-UP trial. Neurological Research and Practice, 2, 40. (doi: 10.1186/s42466-020-00087-9) (PMID:33324940) (PMCID:PMC7678217)

Fudim, M. et al. (2020) Future research prioritization in cardiac resynchronization therapy. American Heart Journal, 223, pp. 48-58. (doi: 10.1016/j.ahj.2020.02.011) (PMID:32163753)

Guthrie, G., Poulter, N., Macdonald, T., Ford, I. , Mackenzie, I., Findlay, E., Williams, B., Brown, M., Lang, C. and Webb, D. (2020) Chronotherapy in hypertension: the devil is in the details. European Heart Journal, 41(16), pp. 1606-1607. (doi: 10.1093/eurheartj/ehaa265) (PMID:32306034)

Hayes, S. et al. (2020) Association between walking pace and stroke incidence: findings from the UK Biobank prospective cohort study. Stroke, 51(5), pp. 1388-1395. (doi: 10.1161/STROKEAHA.119.028064) (PMID:32299326)

Henderson, A. , McSkimming, P., Kinnear, D., McCowan, C. , McIntosh, A., Allan, L. and Cooper, S.-A. (2020) Changes over a decade in psychotropic prescribing for people with intellectual disabilities: prospective cohort study. BMJ Open, 10(9), e036862. (doi: 10.1136/bmjopen-2020-036862) (PMID:32912946)

Israr, M. Z. et al. (2020) Implications of serial measurements of natriuretic peptides in heart failure: insights from BIOSTAT‐CHF. European Journal of Heart Failure, 22(8), pp. 1486-1490. (doi: 10.1002/ejhf.1951) (PMID:32666670)

Jackson, A. M. et al. (2020) Healthcare disparities for women hospitalised with myocardial infarction and angina. European Heart Journal: Quality of Care and Clinical Outcomes, 6(2), pp. 156-165. (doi: 10.1093/ehjqcco/qcz040) (PMID:31346604) (PMCID:PMC7132925)

Jeyam, A. et al. (2020) Clinical impact of residual C-peptide secretion in type 1 diabetes on glycemia and microvascular complications. Diabetes Care, 44(2), pp. 390-398. (doi: 10.2337/dc20-0567) (PMID:33303639)

Katus, H. A., Cleland, J. G.F. and Jaffe, A. S. (2020) Myocardial injury in severe COVID-19 infection. European Heart Journal, 41(22), pp. 2080-2082. (doi: 10.1093/eurheartj/ehaa447) (PMID:32464642)

Kobayashi, M. et al. (2020) Heart failure etiologies and clinical factors precipitating for worsening heart failure: Findings from BIOSTAT-CHF. European Journal of Internal Medicine, 71, pp. 62-69. (doi: 10.1016/j.ejim.2019.10.017) (PMID:31708361)

Lombardi, C. M. et al. (2020) Geographical differences in heart failure characteristics and treatment across Europe: results from the BIOSTAT-CHF study. Clinical Research in Cardiology, 109, pp. 967-977. (doi: 10.1007/s00392-019-01588-7) (PMID:31996990)

Macdougall, I. C. et al. (2020) Intravenous iron dosing and infection risk in patients on hemodialysis: a prespecified secondary analysis of the PIVOTAL trial. Journal of the American Society of Nephrology, 31(4), 2019090972. (doi: 10.1681/ASN.2019090972) (PMID:32253271)

Macdougall, I. C. and Ford, I. (2020) Authors' reply. Journal of the American Society of Nephrology, 31(7), p. 1654. (doi: 10.1681/ASN.2020050624) (PMID:32606033)

Macfarlane, P. W. (2020) New ECG criteria for acute myocardial infarction in patients with left bundle branch block. Journal of the American Heart Association, 9(14), e017119. (doi: 10.1161/jaha.120.017119) (PMID:32627635)

Mackenzie, I. S. et al. (2020) Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial. Lancet, 396(10264), pp. 1745-1757. (doi: 10.1016/S0140-6736(20)32234-0) (PMID:33181081)

Mangion, K. et al. (2020) Displacement encoding with stimulated echoes enables the identification of infarct transmurality early postmyocardial infarction. Journal of Magnetic Resonance Imaging, 52(6), pp. 1722-1731. (doi: 10.1002/jmri.27295) (PMID:32720405)

Mangion, K. et al. (2020) The Chief Scientist Office cardiovascular and pulmonary imaging in SARS Coronavirus disease-19 (CISCO-19) study. Cardiovascular Research, 116(14), pp. 2185-2196. (doi: 10.1093/cvr/cvaa209) (PMID:32702087) (PMCID:PMC7454350)

Mareev, V. Y. et al. (2020) Steroid pulse -therapy in patients With coronAvirus Pneumonia (COVID-19), sYstemic inFlammation And Risk of vEnous thRombosis and thromboembolism (WAYFARER Study). Kardiologiia, 60(6), pp. 15-29. (doi: 10.18087/cardio.2020.6.n1226) (PMID:32720612)

Mark, P. B. , Papworth, R., Ramparsad, N., Tomlinson, L. A., Sahwney, S., Black, C., McConnachie, A. and McCowan, C. (2020) Risk factors associated with biochemically detected and hospitalised acute kidney injury in patients prescribed renin angiotensin system inhibitors. British Journal of Clinical Pharmacology, 86(1), pp. 121-131. (doi: 10.1111/bcp.14141) (PMID:31663151)

Maznyczka, A. M. et al. (2020) One-year outcomes after low-dose intracoronary alteplase during primary percutaneous coronary intervention. The T-TIME randomized trial. Circulation: Cardiovascular Interventions, 13(2), e008855. (doi: 10.1161/CIRCINTERVENTIONS.119.008855) (PMID:32069113)

Maznyczka, A. M. et al. (2020) Effects of intracoronary alteplase on microvascular function in acute myocardial infarction. Journal of the American Heart Association, 9(3), e014066. (doi: 10.1161/JAHA.119.014066) (PMID:31986989) (PMCID:PMC7033872)

McCartney, P. J. et al. (2020) Low-dose intracoronary alteplase during primary percutaneous coronary intervention in patients with acute myocardial infarction: the T-TIME three-arm RCT. Efficacy and Mechanism Evaluation, 7(5), (doi: 10.3310/eme07050) (PMID:33175484)

McCartney, P. J. et al. (2020) Low-dose alteplase during primary percutaneous coronary intervention according to ischemic time. Journal of the American College of Cardiology, 75(12), pp. 1406-1421. (doi: 10.1016/j.jacc.2020.01.041) (PMID:32216909) (PMCID:PMC7109518)

Mitchell, K. et al. (2020) A peer-led intervention to promote sexual health in secondary schools: the STASH feasibility study. Public Health Research, 8(15), (doi: 10.3310/phr08150) (PMID:33252893)

Morrow, A. J. et al. (2020) Rationale and design of the Medical Research Council precision medicine with Zibotentan in microvascular angina (PRIZE) trial. American Heart Journal, 229, pp. 70-80. (doi: 10.1016/j.ahj.2020.07.007) (PMID:32942043)

Nikolaidou, T., Samuel, N. A., Marincowitz, C., Fox, D. J., Cleland, J. G.F. and Clark, A. L. (2020) Electrocardiographic characteristics in patients with heart failure and normal ejection fraction: a systematic review and meta‐analysis. Annals of Noninvasive Electrocardiology, 25(1), e12710. (doi: 10.1111/anec.12710) (PMID:31603593) (PMCID:PMC7358891)

Nkoka, O. (2020) Correlates of appropriate disposal of children's stools in Malawi: a multilevel analysis. BMC Public Health, 20, 604. (doi: 10.1186/s12889-020-08725-2) (PMID:32357929) (PMCID:PMC7195806)

Nkoka, O. , Chuang, T.-W. and Chen, Y.-H. (2020) Effects of malaria interventions during pregnancy on low birth weight in Malawi. American Journal of Preventive Medicine, 59(6), pp. 904-913. (doi: 10.1016/j.amepre.2020.05.021) (PMID:33220759)

Nkoka, O. , Mphande, W. M., Ntenda, P. A.M., Milanzi, E. B., Kanje, V. and Guo, S. J.G. (2020) Multilevel analysis of factors associated with unmet need for family planning among Malawian women. BMC Public Health, 20, 705. (doi: 10.1186/s12889-020-08885-1) (PMID:32414359) (PMCID:PMC7229612)

Ntalla, I. et al. (2020) Multi-ancestry GWAS of the electrocardiographic PR interval identifies 202 loci underlying cardiac conduction. Nature Communications, 11, 2542. (doi: 10.1038/s41467-020-15706-x) (PMID:32439900) (PMCID:PMC7242331)

Ouwerkerk, W. et al. (2020) Effects of combined renin–angiotensin–aldosterone system inhibitor and beta‐blocker treatment on outcomes in heart failure with reduced ejection fraction: insights from BIOSTAT‐CHF and ASIAN‐HF registries. European Journal of Heart Failure, 22(8), pp. 1472-1482. (doi: 10.1002/ejhf.1869) (PMID:32583922)

Palazzuoli, A., Ruocco, G., Franci, B., Evangelista, I., Lucani, B., Nuti, R. and Pellicori, P. (2020) Ultrasound indices of congestion in patients with acute heart failure according to body mass index. Clinical Research in Cardiology, 109(11), pp. 1423-1433. (doi: 10.1007/s00392-020-01642-9) (PMID:32296972)

Pan, D., Pellicori, P. , Walklett, C., Green, A., Masse, A. R., Wood, J., Purdy, J. and Clark, A. L. (2020) Driving habits and reaction times on a driving simulation in older drivers with chronic heart failure. Journal of Cardiac Failure, 26(7), pp. 555-563. (doi: 10.1016/j.cardfail.2020.04.002) (PMID:32433933)

Pandhi, P. et al. (2020) Clinical value of pre‐discharge bio‐adrenomedullin as a marker of residual congestion and high risk of heart failure hospital readmission. European Journal of Heart Failure, 22(4), pp. 683-691. (doi: 10.1002/ejhf.1693) (PMID:31797505)

Parma, Z., Jasilek, A., Greenlaw, N. , Ferrari, R., Ford, I. , Fox, K., Tardif, J.‐C., Tendera, M. and Steg, P. G. (2020) Incident heart failure in outpatients with chronic coronary syndrome: results from the international prospective CLARIFY registry. European Journal of Heart Failure, 22(5), pp. 804-812. (doi: 10.1002/ejhf.1827) (PMID:32297414)

Pellicori, P. (2020) At the heart of COVID-19. European Heart Journal, 41(19), pp. 1830-1832. (doi: 10.1093/eurheartj/ehaa415) (PMID:32405639)

Pellicori, P. , Cleland, J. G.F. and Clark, A. L. (2020) Chronic obstructive pulmonary disease and heart failure: a breathless conspiracy. Heart Failure Clinics, 16(1), pp. 33-44. (doi: 10.1016/j.hfc.2019.08.003) (PMID:31735313)

Pellicori, P. et al. (2020) Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof‐of‐concept, randomised, precision‐medicine, prevention trial. The Heart OMics in AGing (HOMAGE) trial. European Journal of Heart Failure, 22(9), pp. 1711-1723. (doi: 10.1002/ejhf.1716) (PMID:31950604)

Pellicori, P. , Khan, M. J. I., Graham, F. J. and Cleland, J. G.F. (2020) New perspectives and future directions in the treatment of heart failure. Heart Failure Reviews, 25, pp. 147-159. (doi: 10.1007/s10741-019-09829-7) (PMID:31327116) (PMCID:PMC6985084)

Pellicori, P. , Ofstad, A. P., Fitchett, D., Zeller, C., Wanner, C., George, J., Zinman, B., Brueckmann, M. and Lindenfeld, J. (2020) Early benefits of empagliflozin in patients with or without heart failure: findings from EMPA-REG OUTCOME. ESC Heart Failure, 7(6), pp. 3401-3407. (doi: 10.1002/ehf2.12891) (PMID:32915523) (PMCID:PMC7754994)

Pellicori, P. , Zhang, J., Cuthbert, J., Urbinati, A., Shah, P., Kazmi, S., Clark, A. L. and Cleland, J. G.F. (2020) High sensitivity C-reactive protein in chronic heart failure: patient characteristics, phenotypes, and mode of death. Cardiovascular Research, 116(1), pp. 91-100. (doi: 10.1093/cvr/cvz198) (PMID:31350553)

Psotka, M. A. et al. (2020) Conduct of clinical trials in the era of COVID-19: JACC scientific expert panel. Journal of the American College of Cardiology, 76(20), pp. 2368-2378. (doi: 10.1016/j.jacc.2020.09.544) (PMID:33183511)

Purcell, C. , Daw, P., Kerr, C., Cleland, J. , Cowie, A., Dalal, H., Ibbotson, T. , Murphy, C. and Taylor, R. (2020) Protocol for an implementation study of an evidence-based home cardiac rehabilitation programme for people with heart failure and their caregivers in Scotland (SCOT:REACH-HF). BMJ Open, 10(12), e040771. (doi: 10.1136/bmjopen-2020-040771) (PMID:33277287) (PMCID:PMC7722379)

Quint, J. K. et al. (2020) Temporal trends in the incidence, treatment patterns, and outcomes of coronary artery disease and peripheral artery disease in the UK, 2006–2015. European Heart Journal, 41(17), pp. 1636-1649. (doi: 10.1093/eurheartj/ehz880) (PMID:31883328)

Raal, F. J. et al. (2020) Inclisiran for the treatment of heterozygous familial hypercholesterolemia. New England Journal of Medicine, 382(16), pp. 1520-1530. (doi: 10.1056/NEJMoa1913805) (PMID:32197277)

Rahimi, K., Nazarzadeh, M., Pinho-Gomes, A.-C., Woodward, M., Salimi-Khorshidi, G., Ohkuma, T., Fitzpatrick, R., Tarassenko, L., Denis, M. and Cleland, J. (2020) Home monitoring with technology-supported management in chronic heart failure: a randomised trial. Heart, 106(20), pp. 1573-1578. (doi: 10.1136/heartjnl-2020-316773) (PMID:32580977)

Ray, K. K. et al. (2020) Two phase 3 trials of inclisiran in patients with elevated LDL cholesterol. New England Journal of Medicine, 382(16), pp. 1507-1519. (doi: 10.1056/NEJMoa1912387) (PMID:32187462)

Ribeiro, A. H. et al. (2020) Automatic diagnosis of the 12-lead ECG using a deep neural network. Nature Communications, 11, 1760. (doi: 10.1038/s41467-020-15432-4) (PMID:32273514) (PMCID:PMC7145824)

Robertson, C., Pan, J., Kavanagh, K., Ford, I. , McCowan, C. , Bennie, M., Marwick, C. and Leanord, A. (2020) Cost burden of Clostridioides difficile infection to the health service: a retrospective cohort study in Scotland. Journal of Hospital Infection, 106(3), pp. 554-561. (doi: 10.1016/j.jhin.2020.07.019) (PMID:32717202)

Sama, I. E. et al. (2020) A network analysis to identify pathophysiological pathways distinguishing ischemic from non-ischemic heart failure. European Journal of Heart Failure, 22(5), pp. 821-833. (doi: 10.1002/ejhf.1811) (PMID:32243695)

Santema, B. T. et al. (2020) The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure. Clinical Research in Cardiology, 109, pp. 331-338. (doi: 10.1007/s00392-019-01513-y) (PMID:31263996) (PMCID:PMC7042190)

Selvaraj, S. et al. (2020) Serum uric acid, influence of sacubitril/valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction: PARAGON-HF. European Journal of Heart Failure, 22(11), pp. 2093-2101. (doi: 10.1002/ejhf.1984) (PMID:32840930)

Shah, S. et al. (2020) Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure. Nature Communications, 11, 163. (doi: 10.1038/s41467-019-13690-5) (PMID:31919418) (PMCID:PMC6952380)

Shi, C. et al. (2020) Tumor biomarkers: association with heart failure outcomes. Journal of Internal Medicine, 288(2), pp. 207-218. (doi: 10.1111/joim.13053) (PMID:32372544)

Sidik, N. P. et al. (2020) Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Function and CT Coronary Angiogram (CorCTCA) study. American Heart Journal, 221, pp. 48-59. (doi: 10.1016/j.ahj.2019.11.015) (PMID:31911341) (PMCID:PMC7029345)

Simpson, R., Simpson, S., Ramparsad, N., Lawrence, M., Booth, J. and Mercer, S. W. (2020) Effects of mindfulness-based interventions on physical symptoms in people with multiple sclerosis - a systematic review and meta-analysis. Multiple Sclerosis and Related Disorders, 38, 101493. (doi: 10.1016/j.msard.2019.101493) (PMID:31835209)

Simpson, S. A. et al. (2020) An app-, web- and social support-based weight loss intervention for adults with obesity: the HelpMeDoIt! feasibility RCT. Public Health Research, 8(3), (doi: 10.3310/phr08030) (PMID:32186839)

Simpson, S. A. et al. (2020) An app, web and social support based weight loss intervention for adults with obesity: the ‘HelpMeDoIt!’ feasibility randomised controlled trial. Pilot and Feasibility Studies, 6, 133. (doi: 10.1186/s40814-020-00656-4) (PMID:32968544) (PMCID:PMC7501712)

Sixpence, A., Nkoka, O. , Chirwa, G. C., Milanzi, E. B., Mangani, C., Mathanga, D. P. and Ntenda, P. A.M. (2020) Levels of knowledge regarding malaria causes, symptoms, and prevention measures among Malawian women of reproductive age. Malaria Journal, 19, 225. (doi: 10.1186/s12936-020-03294-6) (PMID:32580731) (PMCID:PMC7315553)

Smith, M., Francq, B., McConnachie, A. , Wetherall, K., Pelosi, A. and Morrison, J. (2020) Clinical judgement, case complexity and symptom scores as predictors of outcome in depression: an exploratory analysis. BMC Psychiatry, 20, 125. (doi: 10.1186/s12888-020-02532-0) (PMID:32183799) (PMCID:PMC7076946)

Sorbets, E. et al. (2020) Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry. European Heart Journal, 41(3), pp. 347-356. (doi: 10.1093/eurheartj/ehz660) (PMID:31504434) (PMCID:PMC6964227)

Stähli, B. E. et al. (2020) Rationale and design of the MULTISTARS AMI Trial: a randomized comparison of immediate versus staged complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease. American Heart Journal, 228, pp. 98-108. (doi: 10.1016/j.ahj.2020.07.016) (PMID:32871329)

Stienen, S., Ferreira, J. P., Pitt, B., Cleland, J. G. , Pellicori, P. , Girerd, N., Rossignol, P. and Zannad, F. (2020) Eplerenone prevents an increase in serum carboxy-terminal propeptide of procollagen type I after myocardial infarction complicated by left ventricular dysfunction and/or heart failure. European Journal of Heart Failure, 22(5), pp. 901-903. (doi: 10.1002/ejhf.1812) (PMID:32243646)

Surendran, P. et al. (2020) Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals. Nature Genetics, 52(12), pp. 1314-1332. (doi: 10.1038/s41588-020-00713-x) (PMID:33230300) (PMCID:PMC7610439)

Sze, S., Pellicori, P. , Zhang, J., Weston, J. and Clark, A. (2020) Agreement and classification performance of malnutrition tools in patients with chronic heart failure. Current Developments in Nutrition, 4(6), nzaa071. (doi: 10.1093/cdn/nzaa071) (PMID:32529169) (PMCID:PMC7272189)

Taya, U. et al. (2020) Predictors of left ventricular remodelling in patients with dilated cardiomyopathy - a cardiovascular magnetic resonance study. European Journal of Heart Failure, 22(7), pp. 1160-1170. (doi: 10.1002/ejhf.1734) (PMID:32056322)

Teerlink, J. R. et al. (2020) Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction, GALACTIC‐HF: baseline characteristics and comparison with contemporary clinical trials. European Journal of Heart Failure, 22(11), pp. 2160-2171. (doi: 10.1002/ejhf.2015) (PMID:32985088) (PMCID:PMC7756903)

ter Maaten, J. M. et al. (2020) Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction. Clinical Research in Cardiology, 109, pp. 1048-1059. (doi: 10.1007/s00392-020-01598-w) (PMID:32002631) (PMCID:PMC7375987)

Tromp, J. et al. (2020) Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study. Lancet Global Health, 8(3), e411-e422. (doi: 10.1016/S2214-109X(20)30004-8) (PMID:32087174)

van Vulpen, J. K. et al. (2020) Moderators of exercise effects on cancer-related fatigue: a meta-analysis of individual patient data. Medicine and Science in Sports and Exercise, 52(2), pp. 303-314. (doi: 10.1249/MSS.0000000000002154) (PMID:31524827)

von Haehling, S. et al. (2020) Muscle wasting as an independent predictor of survival in patients with chronic heart failure. Journal of Cachexia, Sarcopenia and Muscle, 11(5), pp. 1242-1249. (doi: 10.1002/jcsm.12603) (PMID:32767518) (PMCID:PMC7567155)

von Wissmann, B. et al. (2020) Informing prevention of stillbirth and preterm birth in Malawi: development of a minimum dataset for health facilities participating in the DIPLOMATIC collaboration. BMJ Open, 10(11), e038859. (doi: 10.1136/bmjopen-2020-038859) (PMID:33234630) (PMCID:PMC7689106)

Voors, A. A. et al. (2020) Effects of danicamtiv, a novel cardiac myosin activator, in heart failure with reduced ejection fraction: experimental data and clinical results from a phase 2a trial. European Journal of Heart Failure, 22(9), pp. 1649-1658. (doi: 10.1002/ejhf.1933) (PMID:32558989) (PMCID:PMC7689751)

Voors, A. A. et al. (2020) Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin–angiotensin–aldosterone inhibitors. European Heart Journal, 41(19), pp. 1810-1817. (doi: 10.1093/eurheartj/ehaa373) (PMID:32388565) (PMCID:PMC7239195)

Ward, L.M. , Cooper, S.-A. , McSkimming, P., Greenlaw, N. , Pacitti, C., Gibson, J., Henderson, A. , Pell, J. and Kinnear, D. (2020) Dental attendance, restoration and extractions in adults with intellectual disabilities compared with the general population: a record linkage study. Journal of Intellectual Disability Research, 64(12), pp. 980-986. (doi: 10.1111/jir.12786) (PMID:32996662)

Wehner, G. J. et al. (2020) Routinely reported ejection fraction and mortality in clinical practice: where does the nadir of risk lie? European Heart Journal, 41(12), pp. 1249-1257. (doi: 10.1093/eurheartj/ehz550) (PMID:31386109)

Welsh, C. et al. (2020) Glycated hemoglobin, prediabetes and the links to cardiovascular disease: data from UK Biobank. Diabetes Care, 43(2), pp. 440-445. (doi: 10.2337/dc19-1683) (PMID:31852727)

Williamson, A. E. , McQueenie, R., Ellis, D. A., McConnachie, A. and Wilson, P. (2020) General practice recording of adverse childhood experiences: a retrospective cohort study of GP records. BJGP Open, 4(1), 20X101011. (doi: 10.3399/bjgpopen20X101011) (PMID:32071039)

Witham, M. D. et al. (2020) Vitamin K supplementation to improve vascular stiffness in chronic kidney disease: the K4Kidneys randomised controlled trial. Journal of the American Society of Nephrology, 31(10), pp. 2434-2445. (doi: 10.1681/ASN.2020020225) (PMID:32817311)

Xin, Y. , Davies, A., Briggs, A. , McCombie, L., Messow, C. M. , Grieve, E. , Leslie, W. S., Taylor, R. and Lean, M. E.J. (2020) Type 2 diabetes remission: 2 year within-trial and lifetime-horizon cost-effectiveness of the Diabetes Remission Clinical Trial (DiRECT)/Counterweight-Plus weight management programme. Diabetologia, 63, pp. 2112-2122. (doi: 10.1007/s00125-020-05224-2) (PMID:32776237) (PMCID:PMC7476973)

Zhyzhneuskaya, S. V., Al-Mrabeh, A., Peters, C., Barnes, A., Aribisala, B., Hollingsworth, K. G., McConnachie, A. , Sattar, N. , Lean, M. E.J. and Taylor, R. (2020) Time course of normalization of functional β-cell capacity in the Diabetes Remission Clinical Trial after weight loss in type 2 diabetes. Diabetes Care, 43(4), pp. 813-820. (doi: 10.2337/dc19-0371) (PMID:32060017)

Zijlstra, L.E., van Velzen, D.M., Simsek, S., Mooijaart, S.P., van Buren, M., Stott J, D.J. , Ford, I. , Jukema, J. and Trompet, S. (2020) The kidney, subclinical thyroid disease and cardiovascular outcomes in older patients. Endocrine Connections, 9(1), pp. 55-62. (doi: 10.1530/EC-19-0502) (PMID:31846431) (PMCID:PMC6993270)

Zonneveld, M. H., Noordam, R., Grond, J., Sabayan, B., Mooijaart, S. P., Macfarlane, P. W., Jukema, J. W. and Trompet, S. (2020) Ventricular repolarization is associated with cognitive function, but not with cognitive decline and brain Magnetic Resonance Imaging (MRI) measurements in older adults. Journal of Clinical Medicine, 9(4), e911. (doi: 10.3390/jcm9040911)

Articles

Adlam, D. et al. (2019) Association of the PHACTR1/EDN1 genetic locus with spontaneous coronary artery dissection. Journal of the American College of Cardiology, 73(1), pp. 58-66. (doi: 10.1016/j.jacc.2018.09.085) (PMID:30621952)

Ambrosy, A. P. et al. (2019) Burden of medical co-morbidities and benefit from surgical revascularization in patients with ischaemic cardiomyopathy. European Journal of Heart Failure, 21(3), pp. 373-381. (doi: 10.1002/ejhf.1404) (PMID:30698316)

Anderson, S. G., Shoaib, A., Myint, P. K., Cleland, J. G. , Hardman, S. M., McDonagh, T. A., Dargie, H., Keavney, B., Garratt, C. J. and Mamas, M. A. (2019) Does rhythm matter in Acute Heart Failure? An insight from the British Society for Heart Failure National Audit. Clinical Research in Cardiology, (doi: 10.1007/s00392-019-01463-5) (PMID:30963233)

Armitage, J. et al. (2019) Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials. Lancet, 393(10170), pp. 407-415. (doi: 10.1016/S0140-6736(18)31942-1) (PMID:30712900) (PMCID:PMC6429627)

Barrow, E. et al. (2019) Functional outcome of intravenous thrombolysis in patients with lacunar infarcts in the WAKE-UP trial. JAMA Neurology, 76(6), pp. 641-649. (doi: 10.1001/jamaneurol.2019.0351) (PMID:30907934)

Bekfani, T. et al. (2019) Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of life. Clinical Research in Cardiology, 108(2), pp. 203-211. (doi: 10.1007/s00392-018-1344-x) (PMID:30051186)

Beldhuis, I. E. et al. (2019) Trajectories of changes in renal function in patients with acute heart failure. Journal of Cardiac Failure, 25(11), pp. 866-874. (doi: 10.1016/j.cardfail.2019.07.004) (PMID:31319165)

Beusekamp, J. C. et al. (2019) Hyperkalemia and treatment with RAAS inhibitors during acute heart failure hospitalizations and their association with mortality. JACC: Heart Failure, 7(11), pp. 970-979. (doi: 10.1016/j.jchf.2019.07.010) (PMID:31606364)

Beverborg, N. G., van der Wal, H., Klip, I. T., Anker, S. D., Cleland, J. G.F. , Dickstein, K., van Veldhuisen, D. J., Voors, A. A. and van der Meer, P. (2019) Differences in clinical profile and outcomes of low iron storage vs defective iron utilization in patients with heart failure: results from the DEFINE-HF and BIOSTAT-CHF studies. JAMA Cardiology, 4(7), pp. 696-701. (doi: 10.1001/jamacardio.2019.1739) (PMID:31188392) (PMCID:PMC6563589)

Bouabdallaoui, N., O'Meara, E., Bernier, V., Komajda, M., Swedberg, K., Tavazzi, L., Borer, J. S., Bohm, M., Ford, I. and Tardif, J.‐C. (2019) Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m. ESC Heart Failure, 6(6), pp. 1199-1207. (doi: 10.1002/ehf2.12513) (PMID:31591826) (PMCID:PMC6989297)

Brazel, D. M. et al. (2019) Exome chip meta-analysis fine maps causal variants and elucidates the genetic architecture of rare coding variants in smoking and alcohol use. Biological Psychiatry, 85(11), pp. 946-955. (doi: 10.1016/j.biopsych.2018.11.024) (PMID:30679032)

Brittenden, J. et al. (2019) Five-Year outcomes of a randomized trial of treatments for varicose veins. New England Journal of Medicine, 381(10), pp. 912-922. (doi: 10.1056/nejmoa1805186) (PMID:31483962)

Bruce, M., Young, D., Turnbull, S., Rooksby, M. , Chadwick, G., Oates, C., Nelson, R., Young-Southward, G., Haig, C. and Minnis, H. (2019) Reactive Attachment Disorder in maltreated young children in foster care. Attachment and Human Development, 21(2), pp. 152-169. (doi: 10.1080/14616734.2018.1499211) (PMID:30021488)

Celis-Morales, C. A. et al. (2019) Walking pace is associated with lower risk of all-cause and cause-specific mortality. Medicine and Science in Sports and Exercise, 51(3), pp. 472-480. (doi: 10.1249/MSS.0000000000001795) (PMID:30303933)

Chauhan, G. et al. (2019) Genetic and lifestyle risk factors for MRI-defined brain infarcts in a population-based setting. Neurology, 92(5), e486-e503. (doi: 10.1212/WNL.0000000000006851) (PMID:30651383) (PMCID:PMC6369905)

Cleland, J. G.F. , Hindricks, G. and Petrie, M. (2019) The shocking lack of evidence for implantable cardioverter defibrillators for heart failure; with or without cardiac resynchronization. European Heart Journal, 40(26), pp. 2128-2130. (doi: 10.1093/eurheartj/ehz409) (PMID:31257403)

Cleland, J. G.F. and Pellicori, P. (2019) Myocardial dysfunction and coronary artery disease as therapeutic targets in heart failure. Circulation, 140(7), pp. 538-541. (doi: 10.1161/CIRCULATIONAHA.119.041523) (PMID:31403847)

Cleland, J. G.F. , Pellicori, P. and Clark, A. L. (2019) Prevention or procrastination for heart failure?: Why we need a universal definition of heart failure. Journal of the American College of Cardiology, 73(19), pp. 2398-2400. (doi: 10.1016/j.jacc.2019.03.471) (PMID:31097158)

Cleland, J. G.F. , van Veldhuisen, D. J. and Ponikowski, P. (2019) The year in cardiology 2018: heart failure. European Heart Journal, 40(8), pp. 651-661. (doi: 10.1093/eurheartj/ehz010) (PMID:30778534)

Conrad, N. et al. (2019) Diagnostic tests, drug prescriptions, and follow-up patterns after incident heart failure: a cohort study of 93,000 UK patients. PLoS Medicine, 16(5), e1002805. (doi: 10.1371/journal.pmed.1002805) (PMID:31112552) (PMCID:PMC6528949)

Conrad, N., Judge, A., Canoy, D., Tran, J., Pinho-Gomes, A. C., Millett, E. R.C., Salimi-Khorshidi, G., Cleland, J. G. , McMurray, J. J.V. and Rahimi, K. (2019) Temporal trends and patterns in mortality after incident heart failure: a longitudinal analysis of 86 000 individuals. JAMA Cardiology, 4(11), pp. 1102-1111. (doi: 10.1001/jamacardio.2019.3593) (PMID:31479100) (PMCID:PMC6724155)

Cook, J. A., Fergusson, D. A., Ford, I. , Gonen, M., Kimmelman, J., Korn, E. L. and Begg, C. B. (2019) There is still a place for significance testing in clinical trials. Clinical Trials, 16(3), pp. 223-224. (doi: 10.1177/1740774519846504) (PMID:31068002)

Davie-Smith, F., Paul, L., Stuart, W., Kennon, B., Young, R. and Wyke, S. (2019) The influence of socio-economic deprivation on mobility, participation, and quality of life following major lower extremity amputation in the West of Scotland. European Journal of Vascular and Endovascular Surgery, 57(4), pp. 554-560. (doi: 10.1016/j.ejvs.2018.10.011) (PMID:30905506)

de Boer, R. A. et al. (2019) Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology. European Journal of Heart Failure, 21(3), pp. 272-285. (doi: 10.1002/ejhf.1406) (PMID:30714667) (PMCID:PMC6607480)

de las Fuentes, L. et al. (2019) Genome-wide meta-analysis of variant-by-diuretic interactions as modulators of lipid traits in persons of European and African ancestry. Pharmacogenomics Journal, 20(3), pp. 482-493. (doi: 10.1038/s41397-019-0132-y) (PMID:31806883) (PMCID:PMC7260079)

Dunn, K., Kinnear, D. , Jahoda, A. and McConnachie, A. (2019) Mental health and well-being of fathers of children with intellectual disabilities: systematic review and meta-analysis. BJPsych Open, 5(6), e96. (doi: 10.1192/bjo.2019.75) (PMID:31694727) (PMCID:PMC6854361)

El-Tawil, S., Mair, G., Huang, X., Sakka, E., Palmer, J., Ford, I. , Kalra, L., Wardlaw, J. and Muir, K. W. (2019) Observer agreement on CT Perfusion imaging in acute ischemic stroke. Stroke, 50(11), pp. 3108-3114. (doi: 10.1161/STROKEAHA.119.026238) (PMID:31928512) (PMCID:PMC6824508)

Elffers, T.W., Trompet, S., de Mutsert, R., Maan, A.C., Lamb, H.J., Macfarlane, P.W., Rosendaal, F.R. and Jukema, J.W. (2019) Borderline Q-waves in individuals without overt cardiovascular disease: relations with adiposity, subclinical atherosclerosis and vascular stiffness. International Journal of Cardiology, 274, pp. 331-336. (doi: 10.1016/j.ijcard.2018.08.088) (PMID:30195838)

Ellervik, C. et al. (2019) Assessment of the relationship between genetic determinants of thyroid function and atrial fibrillation: a Medelian randomization study. JAMA Cardiology, 4(2), pp. 144-152. (doi: 10.1001/jamacardio.2018.4635) (PMID:30673084) (PMCID:PMC6396813)

Felker, G. M., Borentain, M., Cleland, J. G.F. , DeSouza, M. M., Kessler, P. D., O'Connor, C. M., Seiffert, D., Teerlink, J. R., Voors, A. A. and McMurray, J. J.V. (2019) Rationale and design for the development of a novel nitroxyl donor in patients with acute heart failure. European Journal of Heart Failure, 21(8), pp. 1022-1031. (doi: 10.1002/ejhf.1504) (PMID:31168885)

Ferrari, R., Ford, I. , Fox, K., Marzilli, M., Tendera, M., Widimský, P., Challeton, J.-P. and Danchin, N. (2019) A randomized, double-blind, placebo-controlled trial to assess the efficAcy and safety of Trimetazidine in patients with angina pectoris having been treated by percutaneous coronary intervention (ATPCI study): rationale, design, and baseline characteristics. American Heart Journal, 210, pp. 98-107. (doi: 10.1016/j.ahj.2018.12.015) (PMID:30771737)

Ferreira, J. P. et al. (2019) Clinical correlates and outcome associated with changes in 6-minute walking distance in patients with heart failure: findings from the BIOSTAT-CHF study. European Journal of Heart Failure, 21(2), pp. 218-226. (doi: 10.1002/ejhf.1380) (PMID:30600578)

Ferreira, J. P. et al. (2019) Potential spironolactone effects on collagen metabolism biomarkers in patients with uncontrolled blood pressure. Heart, 105(4), pp. 307-314. (doi: 10.1136/heartjnl-2018-313182) (PMID:30121630)

Ferreira, J. P. et al. (2019) Proteomic bioprofiles and mechanistic pathways of progression to heart failure: the HOMAGE study. Circulation, 12(5), e005897. (doi: 10.1161/CIRCHEARTFAILURE.118.005897) (PMID:31104495)

Ford, T. J. et al. (2019) Ischemia and no obstructive coronary artery disease: prevalence and correlates of coronary vasomotion disorders. Circulation: Cardiovascular Interventions, 12(12), e008126. (doi: 10.1161/CIRCINTERVENTIONS.119.008126) (PMID:31833416) (PMCID:PMC6924940)

Fröhlich, H. et al. (2019) Epidemiology and long-term outcome in outpatients with chronic heart failure in Northwestern Europe. Heart, 105(16), pp. 1252-1259. (doi: 10.1136/heartjnl-2018-314256) (PMID:30792238)

Galinovic, I. et al. (2019) Post-hoc analysis of outcome of intravenous thrombolysis in infarcts of infratentorial localization in the WAKE-UP trial. Frontiers in Neurology, 10, 983. (doi: 10.3389/fneur.2019.00983) (PMID:31572293) (PMCID:PMC6749039)

Gandhi, S. et al. (2019) Living alone and cardiovascular disease outcomes. Heart, 105(14), pp. 1087-1095. (doi: 10.1136/heartjnl-2018-313844) (PMID:30792241)

Greenberg, B. et al. (2019) Association of rivaroxaban with thromboembolic events in patients with heart failure, coronary disease, and sinus rhythm: a post hoc analysis of the COMMANDER HF trial. JAMA Cardiology, 4(6), pp. 515-523. (doi: 10.1001/jamacardio.2019.1049) (PMID:31017637) (PMCID:PMC6487904)

Haig, C. et al. (2019) Current smoking and prognosis after acute ST-segment elevation myocardial infarction: new pathophysiological insights. JACC: Cardiovascular Imaging, 12(6), pp. 993-1003. (doi: 10.1016/j.jcmg.2018.05.022) (PMID:30031700) (PMCID:PMC6547246)

Halliday, B. P. et al. (2019) Outcome in dilated cardiomyopathy related to the extent, location and pattern of late gadolinium enhancement. JACC: Cardiovascular Imaging, 12(8 Pt 2), pp. 1645-1655. (doi: 10.1016/j.jcmg.2018.07.015) (PMID:30219397) (PMCID:PMC6682609)

Halliday, B. P., Cleland, J. G.F. and Prasad, S. K. (2019) When can heart failure treatment be stopped safely? – Authors' reply. Lancet, 394(10194), pp. 217-218. (doi: 10.1016/S0140-6736(19)30499-4)

Halliday, B. P. et al. (2019) Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial. Lancet, 393(10166), pp. 61-73. (doi: 10.1016/S0140-6736(18)32484-X) (PMID:30429050) (PMCID:PMC6319251)

Harris, L., Hankey, C., Jones, N., Murray, H., Pert, C., Tobin, J., Boyle, S., Shearer, R. and Melville, C.A. (2019) Process evaluation of a cluster-randomised controlled trial of multi-component weight management programme in adults with intellectual disabilities and obesity. Journal of Intellectual Disability Research, 63(1), pp. 49-63. (doi: 10.1111/jir.12563) (PMID:30417575)

Henderson, M. et al. (2019) Trial of healthy relationship initiatives for the very early years (THRIVE), evaluating Enhanced Triple P for Baby and Mellow Bumps for those with additional social and care needs during pregnancy and their infants who are at higher risk of maltreatment: study protocol for a randomised controlled trial. Trials, 20, 499. (doi: 10.1186/s13063-019-3571-5) (PMID:31412902) (PMCID:PMC6694522)

Hoshino, T. et al. (2019) Non-cardioembolic stroke/transient ischaemic attack in Asians and non-Asians: A post-hoc analysis of the PERFORM study. European Stroke Journal, 4(1), pp. 65-74. (doi: 10.1177/2396987318797245) (PMID:31165096) (PMCID:PMC6533862)

House, A. A. et al. (2019) Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies conference. Kidney International, 95(6), pp. 1304-1317. (doi: 10.1016/j.kint.2019.02.022) (PMID:31053387)

Irvin, M. R. et al. (2019) Genome wide association study of apparent treatment resistant hypertension in the CHARGE consortium: the CHARGE pharmacogenetics working group. American Journal of Hypertension, 32(12), pp. 1146-1153. (doi: 10.1093/ajh/hpz150) (PMID:31545351)

Johnson, M. J. et al. (2019) Oral modified release morphine for breathlessness in chronic heart failure: a randomised placebo-controlled trial. ESC Heart Failure, 6(6), pp. 1149-1160. (doi: 10.1002/ehf2.12498) (PMID:31389157) (PMCID:PMC6989293)

Jones, G. T. et al. (2019) Maintained physical activity and physiotherapy in the management of distal arm pain: a randomised controlled trial. RMD Open, 5(1), e000810. (doi: 10.1136/rmdopen-2018-000810) (PMID:30997149) (PMCID:PMC6446181)

Justice, A. E. et al. (2019) Protein-coding variants implicate novel genes related to lipid homeostasis contributing to body-fat distribution. Nature Genetics, 51(3), pp. 452-469. (doi: 10.1038/s41588-018-0334-2) (PMID:30778226)

Kamat, M. A., Blackshaw, J. A., Young, R. , Surendran, P., Burgess, S., Danesh, J., Butterworth, A. S. and Staley, J. R. (2019) PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations. Bioinformatics, 35(22), pp. 4851-4853. (doi: 10.1093/bioinformatics/btz469) (PMID:31233103) (PMCID:PMC6853652)

Kaptoge, S. et al. (2019) Longer-term efficiency and safety of increasing the frequency of whole blood donation (INTERVAL): extension study of a randomised trial of 20 757 blood donors. Lancet Haematology, 6(10), e510-e520. (doi: 10.1016/S2352-3026(19)30106-1) (PMID:31383583) (PMCID:PMC7029279)

Kaptoge, S. et al. (2019) World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions. Lancet Global Health, 7(10), e1332-e1345. (doi: 10.1016/S2214-109X(19)30318-3) (PMID:31488387)

Keeble, T. R. et al. (2019) Percutaneous haemodynamic and renal support in patients presenting with decompensated heart failure: A multi-centre efficacy study using the Reitan Catheter Pump (RCP). International Journal of Cardiology, 275, pp. 53-58. (doi: 10.1016/j.ijcard.2018.09.085) (PMID:30342873)

Kitas, G. D. et al. (2019) A multicenter, randomized, placebo‐controlled trial of atorvastatin for the primary prevention of cardiovascular events in patients with rheumatoid arthritis. Arthritis and Rheumatology, 71(9), pp. 1437-1449. (doi: 10.1002/art.40892) (PMID:30983166) (PMCID:PMC6771601)

Kotecha, D. et al. (2019) Impact of renal impairment on beta-blocker efficacy in patients with heart failure. Journal of the American College of Cardiology, 74(23), pp. 2893-2904. (doi: 10.1016/j.jacc.2019.09.059) (PMID:31806133)

Larsson, S. C. et al. (2019) Serum magnesium and calcium levels in relation to ischemic stroke. Neurology, 92(9), e944-e950. (doi: 10.1212/WNL.0000000000007001) (PMID:30804065) (PMCID:PMC6404465)

Lean, M. E.J. et al. (2019) Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial. Lancet Diabetes and Endocrinology, 7(5), pp. 344-355. (doi: 10.1016/S2213-8587(19)30068-3) (PMID:30852132)

Lee, M. M.Y. et al. (2019) Invasive versus medical management in patients with prior coronary artery bypass surgery with a non-ST segment elevation acute coronary syndrome: a pilot randomized controlled trial. Circulation: Cardiovascular Interventions, 12(8), e007830. (doi: 10.1161/CIRCINTERVENTIONS.119.007830) (PMID:31362541)

Lees, J. S. et al. (2019) Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease. Nature Medicine, 25, pp. 1753-1760. (doi: 10.1038/s41591-019-0627-8) (PMID:31700174) (PMCID:PMC6858876)

Leslie, K.H., McCowan, C. and Pell, J.P. (2019) Adherence to cardiovascular medication: a review of systematic reviews. Journal of Public Health, 41(1), e84-e94. (doi: 10.1093/pubmed/fdy088) (PMID:29850883) (PMCID:PMC6459362)

Lyall, D. M. et al. (2019) Assessing for interaction between APOE ε4, sex and lifestyle on cognitive abilities. Neurology, 92, e2691-e2698. (doi: 10.1212/WNL.0000000000007551) (PMID:31028125) (PMCID:PMC6556094)

Macdougall, I. and Ford, I. (2019) Intravenous Iron and Maintenance Hemodialysis. New England Journal of Medicine, 380(24), e46. (doi: 10.1056/NEJMc1902945) (PMID:31189050)

Macdougall, I. C. et al. (2019) Intravenous iron in patients undergoing maintenance hemodialysis. New England Journal of Medicine, 380(5), pp. 447-458. (doi: 10.1056/NEJMoa1810742) (PMID:30365356)

Macdougall, I. C. et al. (2019) Correction: Intravenous iron in patients undergoing maintenance hemodialysis. New England Journal of Medicine, 380(5), p. 502. (doi: 10.1056/NEJMx180044) (PMID:30641026)

Mahinrad, S. et al. (2019) Spatial QRS-T angle and cognitive decline in older subjects. Journal of Alzheimer's Disease, 67(1), pp. 279-289. (doi: 10.3233/JAD-180633) (PMID:30584139)

Malik, R. et al. (2019) Publisher Correction: Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nature Genetics, (doi: 10.1038/s41588-019-0449-0) (PMID:31160810)

Mangion, K. et al. (2019) Circumferential strain predicts major adverse cardiovascular events following an acute ST-segment-elevation myocardial infarction. Radiology, 290(2), pp. 329-337. (doi: 10.1148/radiol.2018181253) (PMID:30457480)

Mangion, K. et al. (2019) Predictors of segmental myocardial functional recovery in patients after an acute ST-elevation myocardial infarction. European Journal of Radiology, 112, pp. 121-129. (doi: 10.1016/j.ejrad.2019.01.010) (PMID:30777200) (PMCID:PMC6390173)

Markousis-Mavrogenis, G. et al. (2019) The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF Study. European Journal of Heart Failure, 21(8), pp. 965-973. (doi: 10.1002/ejhf.1482) (PMID:31087601)

Markus, H. S. et al. (2019) Stenting for symptomatic vertebral artery stenosis: a preplanned pooled individual patient data analysis. Lancet Neurology, 18(7), pp. 666-673. (doi: 10.1016/S1474-4422(19)30149-8) (PMID:31130429)

Maznyczka, A. M. et al. (2019) Sex-based associations with microvascular injury and outcomes after ST-segment elevation myocardial infarction. Open Heart, 6(1), e000979. (doi: 10.1136/openhrt-2018-000979) (PMID:31168381) (PMCID:PMC6519583)

McCartney, P. J. et al. (2019) Effect of low-dose intracoronary alteplase during primary percutaneous coronary intervention on microvascular obstruction in patients with acute myocardial infarction: a randomized clinical trial. JAMA: Journal of the American Medical Association, 321(1), pp. 56-68. (doi: 10.1001/jama.2018.19802) (PMID:30620371) (PMCID:PMC6583564)

McCowan, C. et al. (2019) Comparing uptake across breast, cervical and bowel screening at an individual level: a retrospective cohort study. British Journal of Cancer, 121(8), pp. 710-714. (doi: 10.1038/s41416-019-0564-9) (PMID:31481732) (PMCID:PMC6889480)

McMillan, T.M. , Graham, L., Pell, J.P. , McConnachie, A. and Mackay, D.F. (2019) The lifetime prevalence of hospitalised head injury in Scottish prisons: A population study. PLoS ONE, 14(1), e0210427. (doi: 10.1371/journal.pone.0210427) (PMID:30653552) (PMCID:PMC6336306)

McQueenie, R., Ellis, D. A., McConnachie, A. , Wilson, P. and Williamson, A. E. (2019) Morbidity, mortality and missed appointments in healthcare: a national retrospective data linkage study. BMC Medicine, 17, 2. (doi: 10.1186/s12916-018-1234-0) (PMID:30630493) (PMCID:PMC6329132)

Mehra, M. R. et al. (2019) A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial. European Heart Journal, 40(44), pp. 3593-3602. (doi: 10.1093/eurheartj/ehz427) (PMID:31461239) (PMCID:PMC6868495)

Mercer, S. W. , Fitzpatrick, B., Grant, L., Chng, N. R. , McConnachie, A. , Bakhshi, A., James-Rae, G., O'Donnell, C. A. and Wyke, S. (2019) Effectiveness of community-links practitioners in areas of high socioeconomic deprivation. Annals of Family Medicine, 17(6), pp. 518-525. (doi: 10.1370/afm.2429) (PMID:31712290)

Metra, M. et al. (2019) Effects of serelaxin in patients with acute heart failure. New England Journal of Medicine, 381(8), pp. 716-726. (doi: 10.1056/NEJMoa1801291) (PMID:31433919)

Millar, L., McConnachie, A. , Minnis, H. , Wilson, P., Thompson, L. , Anzulewicz, A., Sobota, K., Rowe, P., Gillberg, C. and Delafield-Butt, J. (2019) Phase 3 diagnostic evaluation of a smart tablet serious game to identify autism in 760 children 3–5 years old in Sweden and the United Kingdom. BMJ Open, 9(7), e026226. (doi: 10.1136/bmjopen-2018-026226) (PMID:31315858) (PMCID:PMC6661582)

Mooijaart, S. P. et al. (2019) Association between levothyroxine treatment and thyroid-related symptoms among adults aged 80 years and older with subclinical hypothyroidism. JAMA: Journal of the American Medical Association, 322(20), pp. 1977-1986. (doi: 10.1001/jama.2019.17274) (PMID:31664429)

Mordi, I. R. et al. (2019) Prognostic significance of changes in heart rate following uptitration of beta-blockers in patients with sub-optimally treated heart failure with reduced ejection fraction in sinus rhythm versus atrial fibrillation. Clinical Research in Cardiology, 108(7), pp. 797-805. (doi: 10.1007/s00392-018-1409-x) (PMID:30610382) (PMCID:PMC6584244)

Morrison, A. P. et al. (2019) Cognitive behavioural therapy for clozapine-resistant schizophrenia: the FOCUS RCT. Health Technology Assessment, 23(7),

Mueller, C. et al. (2019) Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations. European Journal of Heart Failure, 21(6), pp. 715-731. (doi: 10.1002/ejhf.1494) (PMID:31222929)

Neilson, A. R. et al. (2019) Cost-utility of maintained physical activity and physiotherapy in the management of distal arm pain: an economic evaluation of data from a randomized controlled trial. Family Practice, 36(2), pp. 179-186. (doi: 10.1093/fampra/cmy047) (PMID:29878103) (PMCID:PMC6425461)

Nkoka, O. , Chipeta, M. S., Chuang, Y.-C., Fergus, D. and Chuang, K.-Y. (2019) A comparative study of the prevalence of and factors associated with insecticide-treated nets usage among children under 5 years of age in households that already own nets in Malawi. Malaria Journal, 18(1), 43. (doi: 10.1186/s12936-019-2667-4) (PMID:30786905) (PMCID:PMC6383286)

Nkoka, O. , Chuang, T.-W. and Chen, Y.-H. (2019) Effects of insecticide-treated net access and use on infant mortality in Malawi: A pooled analysis of demographic health surveys. Preventive Medicine, 127, 105790. (doi: 10.1016/j.ypmed.2019.105790) (PMID:31398410)

Nkoka, O. , Chuang, T.-W. and Chen, Y.-H. (2019) Multilevel analysis of factors associated with treatment-seeking behaviors among caregivers with febrile children in Malawi. American Journal of Tropical Medicine and Hygiene, 100(6), pp. 1454-1465. (doi: 10.4269/ajtmh.18-0900) (PMID:30994089) (PMCID:PMC6553897)

Nkoka, O. , Ntenda, P. A.M., Kanje, V., Milanzi, E. B. and Arora, A. (2019) Determinants of timely initiation of breast milk and exclusive breastfeeding in Malawi: a population-based cross-sectional study. International Breastfeeding Journal, 14, 37. (doi: 10.1186/s13006-019-0232-y) (PMID:31428184) (PMCID:PMC6697947)

Nkoka, O. , Ntenda, P. A. M., Senghore, T. and Bass, P. (2019) Maternal overweight and obesity and the risk of caesarean birth in Malawi. Reproductive Health, 16, 40. (doi: 10.1186/s12978-019-0700-2) (PMID:30944000) (PMCID:PMC6448310)

Ntenda, P. A. M., Mhone, T. G. and Nkoka, O. (2019) High maternal body mass index is associated with an early-onset of overweight/obesity in pre-school-aged children in Malawi. A multilevel analysis of the 2015-16 Malawi demographic and health survey. Journal of Tropical Pediatrics, 65(2), pp. 147-159. (doi: 10.1093/tropej/fmy028) (PMID:29800293)

Ntenda, P. A. M., Mwenyenkulu, E. T., Putthanachote, N., Nkoka, O. , Mhone, T. G., Motsa, M. P. S. and Tizifa, T. (2019) Predictors of uptake of newly introduced vaccines in Malawi - monovalent human rotavirus and pneumococcal conjugate vaccines: Evidence from the 2015-16 Malawi demographic and health survey. Journal of Tropical Pediatrics, 65(3), pp. 287-296. (doi: 10.1093/tropej/fmy050) (PMID:30085260)

Ntenda, P. A. M., Nkoka, O. , Nana, A. W., Majoni, P., Mhone, T. G., Tizifa, T., Mwenyenkulu, E. T., Kazambwe, J. F., Putthanachote, N. and Motsa, M. P. S. (2019) Factors associated with completion of childhood immunization in Malawi: a multilevel analysis of the 2015-16 Malawi demographic and health survey. Transactions of the Royal Society of Tropical Medicine and Hygiene, 113(9), pp. 534-544. (doi: 10.1093/trstmh/trz029) (PMID:31034078)

Nuzzi, V. et al. (2019) Clinical and prognostic association of total atrial conduction time in patients with heart failure: a report from Studies Investigating Co-morbidities Aggravating Heart Failure. Journal of Cardiovascular Medicine, 20(7), pp. 442-449. (doi: 10.2459/JCM.0000000000000802) (PMID:30985354)

O'Brien, R., Buston, K. , Wight, D. , McGee, E., White, J. and Henderson, M. (2019) A realist process evaluation of Enhanced Triple P for Baby and Mellow Bumps, within a Trial of Healthy Relationship Initiatives for the Very Early-years (THRIVE): study protocol for a randomized controlled trial. Trials, 20, 351. (doi: 10.1186/s13063-019-3395-3) (PMID:31196169) (PMCID:PMC6567913)

O'Connor, R. C. et al. (2019) SAFETEL randomised controlled feasibility trial of a safety planning intervention with follow-up telephone contact to reduce suicidal behaviour: study protocol. BMJ Open, 9(2), e025591. (doi: 10.1136/bmjopen-2018-025591) (PMID:30782938) (PMCID:PMC6377516)

Palazzuoli, A., Ruocco, G., Pellicori, P. , Incampo, E., Di Tommaso, C., Favilli, R., Evangelista, I., Nuti, R. and Testani, J. M. (2019) The prognostic role of different renal function phenotypes in patients with acute heart failure. International Journal of Cardiology, 276, pp. 198-203. (doi: 10.1016/j.ijcard.2018.11.108) (PMID:30503187)

Parma, Z., Young, R. , Roleder, T., Marona, M., Ford, I. , Tendera, M., Steg, P. G. and Stępińska, J. (2019) Management strategies and 5-year outcomes in Polish patients with stable coronary artery disease versus other European countries: data from the CLARIFY registry. Polish Archives of Internal Medicine, 129(5), pp. 327-334. (doi: 10.20452/pamw.14789) (PMID:30951032)

Patel, R. et al. (2019) Subsequent event risk in individuals with established coronary heart disease: design and rationale of the GENIUS-CHD Consortium. Circulation: Genomic and Precision Medicine, (doi: 10.1161/CIRCGEN.119.002470) (PMID:30896328)

Patel, R. S. et al. (2019) Association of chromosome 9p21 with subsequent coronary heart disease events: a GENUIS-CHD study of individual participant data. Circulation: Genomic and Precision Medicine, 12(4), e002471. (doi: 10.1161/CIRCGEN.119.002471) (PMID:30897348)

Paterson, C. et al. (2019) Radiotherapy-induced xerostomia: a randomised, double-blind, controlled trial of Visco-ease™ oral spray compared with placebo in patients with cancer of the head and neck. British Journal of Oral and Maxillofacial Surgery, 57(10), pp. 1119-1125. (doi: 10.1016/j.bjoms.2019.10.300) (PMID:31672256)

Paul, L., Renfrew, L., Freeman, J., Murray, H., Weller, B., Mattison, P., McConnachie, A. , Heggie, R., Wu, O. and Coulter, E. H. (2019) Web-based physiotherapy for people affected by multiple sclerosis: a single blind, randomized controlled feasibility study. Clinical Rehabilitation, 33(3), pp. 473-484. (doi: 10.1177/0269215518817080) (PMID:30514108)

Pellicori, P. , Shah, P., Cuthbert, J., Urbinati, A., Zhang, J., Kallvikbacka-Bennett, A., Clark, A. L. and Cleland, J. G.F. (2019) Prevalence, pattern and clinical relevance of ultrasound indices of congestion in outpatients with heart failure. European Journal of Heart Failure, 21(7), pp. 904-916. (doi: 10.1002/ejhf.1383) (PMID:30666769)

Pellicori, P. , Urbinati, A., Kaur, K., Zhang, J., Shah, P., Kazmi, S., Capucci, A., Cleland, J. G.F. and Clark, A. L. (2019) Prevalence and incidence of atrial fibrillation in ambulatory patients with heart failure. American Journal of Cardiology, 124(10), pp. 1554-1560. (doi: 10.1016/j.amjcard.2019.08.018) (PMID:31558271)

Pennells, L. et al. (2019) Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies. European Heart Journal, 40(7), pp. 621-631. (doi: 10.1093/eurheartj/ehy653) (PMID:30476079) (PMCID:PMC6374687)

Picard, F., Bhatt, D. L., Ducrocq, G., Elbez, Y., Ferrari, R., Ford, I. , Tardif, J. C., Tendera, M., Fox, K. M. and Steg, P. G. (2019) Generalizability of the REDUCE-IT trial in patients with stable coronary artery disease. Journal of the American College of Cardiology, 73(11), pp. 1362-1364. (doi: 10.1016/j.jacc.2019.01.016) (PMID:30819552)

Raber, I., McCarthy, C. P., Vaduganathan, M., Bhatt, D. L., Wood, D. A., Cleland, J. G.F. , Blumenthal, R. S. and McEvoy, J. W. (2019) The rise and fall of aspirin in the primary prevention of cardiovascular disease. Lancet, 393(10186), pp. 2155-2167. (doi: 10.1016/S0140-6736(19)30541-0)

Rankin, J., Rowen, D., Howe, A., Cleland, J. G.F. and Whitty, J. A. (2019) Valuing health-related quality of life in heart failure: a systematic review of methods to derive quality-adjusted life years (QALYs) in trial-based cost–utility analyses. Heart Failure Reviews, 24(4), pp. 549-563. (doi: 10.1007/s10741-019-09780-7) (PMID:30903357) (PMCID:PMC6560006)

Ribeiro, A. L. P. et al. (2019) Tele-electrocardiography and bigdata: the CODE (Clinical Outcomes in Digital Electrocardiography) study. Journal of Electrocardiology, 57(Suppl), S75-S78. (doi: 10.1016/j.jelectrocard.2019.09.008) (PMID:31526573)

Rostamian, S., de Haan, S., van der Grond, J., van Buchem, M. A., Ford, I. , Jukema, J. W. and Sabayan, B. (2019) Cognitive function in dementia-free subjects and survival in old Age: The PROSPER study. American Journal of Medicine, 132(12), 1466-1474.e4. (doi: 10.1016/j.amjmed.2019.06.001) (PMID:31228412)